myocarditis: Myocarditis is a condition that is characterized by inflammation of the heart muscle (myocardium). Some affected people have no noticeable symptoms of the condition. When present, signs and symptoms may include chest pain, abnormal heartbeat, shortness of breath, fatigue, signs of infection (i.e. fever, headache, sore throat, diarrhea), and leg swelling. Myocarditis can be caused by a variety of factors including infections (viral, bacterial, parasitic, and fungal), allergic reactions to certain medications, and exposure to certain chemicals. It can also be associated with other inflammatory conditions such as lupus , Wegener's granulomatosis , giant cell arteritis and Takayasu's arteritis. Most cases occur sporadically in people with no family history of the condition. Treatment aims to address the underlying cause of the condition. Medications and, rarely, a heart transplant may be needed if the heart muscle becomes weak. [ https://rarediseases.info.nih.gov/diseases/7137/myocarditis ]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2118 |
4. Check minimum number of eventsNone |
2118 |
5. Include endpointsNone |
2118 |
6. Filter based on genotype QC (FinnGen only) |
2118 |
Control definitions (FinnGen only)
- Control exclude
- FG_CVD
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Myocarditis
based on the number of shared cases.
Similar with more cases:
- Other heart diseases
- Other heart diseases, wide
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 17932 | 5852 | 11924 |
| Only index persons | 14873 | 4677 | 10196 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.28 | 0.17 | 0.33 |
| Only index persons | 0.32 | 0.17 | 0.39 |
| Median age at first event (years) | |||
| Whole population | 39.71 | 50.66 | 34.06 |
| Only index persons | 36.53 | 48.02 | 31.26 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2118 | 849 | 1269 |
| Unadjusted period prevalence (%) | 0.45 | 0.29 | 0.56 |
| Median age at first event (years) | 43.52 | 47.63 | 40.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1907
- Matched controls
- 19063
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
210.7
323.0
360
21
I40.9
ICD-10 Finland
Acute myocarditis, unspecified
+∞
323.0
846
*
205
Kela drug reimbursment
Chronic hypertension
+∞
323.0
351
*
C07AB07
ATC
bisoprolol; oral
11.8
323.0
1095
1950
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
65.3
323.0
619
139
I25.1
ICD-10 Finland
Atherosclerotic heart disease
136.4
323.0
356
32
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
25.8
323.0
621
350
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
20.9
323.0
633
442
I48
ICD-10 Finland
Atrial fibrillation and flutter
129.5
323.0
477
49
I41.8*D86.8
ICD-10 Finland
Sarcoid myocarditis
+∞
323.0
318
*
207
Kela drug reimbursment
Chronic arrhythmias
237.0
314.7
317
16
I50.9
ICD-10 Finland
Heart failure, unspecified
213.8
301.5
306
17
B01AA03
ATC
warfarin; systemic
30.6
300.8
410
169
AN1
HP
Coronary angiography
83.9
289.2
322
46
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
233.8
277.0
280
14
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
439.7
238.3
234
6
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
164.9
235.8
245
17
C03CA01
ATC
furosemide; systemic
9.0
230.6
543
807
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
217.9
205
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.9
216.1
981
3367
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
+∞
215.7
203
*
I41.8
ICD-10 Finland
Myocarditis in other diseases classified elsewhere
+∞
204.9
193
*
TFP20
NOMESCO Finland
Cardiodefibrillation
2218.6
197.2
188
*
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
46.2
194.9
240
59
R07.4
ICD-10 Finland
Chest pain, unspecified
5.6
189.8
670
1688
I44.2
ICD-10 Finland
Atrioventricular block, complete
+∞
188.7
178
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
108.6
188.3
204
21
I40.0
ICD-10 Finland
Infective myocarditis
+∞
180.0
170
*
C03DA01
ATC
spironolactone; oral
18.5
174.6
278
174
C09AA05
ATC
ramipril; oral
7.0
172.8
476
859
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
72.5
166.6
190
29
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
165.0
156
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.8
164.2
381
526
I50.1
ICD-10 Finland
Left ventricular failure
+∞
163.9
155
*
XF404
NOMESCO Finland
Ambulatory ECG
15.4
157.7
270
202
I51.4
ICD-10 Finland
Myocarditis, unspecified
177.8
157.2
163
10
I42.0
ICD-10 Finland
Dilated cardiomyopathy
+∞
156.4
148
*
C07AB02
ATC
metoprolol; systemic
7.9
155.4
387
594
I50.0
ICD-10 Finland
Congestive heart failure
324.8
148.8
149
5
C01BD01
ATC
amiodarone; systemic
769.6
147.1
143
*
XF400
NOMESCO Finland
ECG with 12 standard connections
6.5
146.3
422
794
42299
ICD-8 Finland
Acute myocarditis, Unspecified
+∞
143.5
136
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
8.6
142.9
333
456
I47.2
ICD-10 Finland
Ventricular tachycardia
310.1
142.5
143
5
4229X
ICD-9 Finland
Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]
+∞
142.4
135
*
C01DA14
ATC
isosorbide mononitrate; oral
23.3
138.6
203
97
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
172.7
138.4
144
9
XF402
NOMESCO Finland
ECG with work load test
10.4
136.4
282
312
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
46.8
136.0
167
39
42297
ICD-8 Finland
Acute myocarditis, Suspecta
+∞
131.8
125
*
I10
ICD-10 Finland
Essential (primary) hypertension
3.6
129.6
794
3162
B01AC04
ATC
clopidogrel; oral
17.9
129.0
207
129
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
78.5
123.3
139
19
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
90.0
120.9
134
16
81
HP
Angiography of the heart and coronary arteries
82.7
116.9
131
17
B01AF02
ATC
apixaban; oral
40.7
116.4
147
39
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
+∞
115.8
110
*
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
110.3
114.4
124
12
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
13.0
114.0
209
179
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
396.5
113.7
113
*
H02AB06
ATC
prednisolone; systemic
3.0
108.9
974
4918
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
274.8
102.8
104
*
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
+∞
101.9
97
*
C01AA05
ATC
digoxin; systemic
33.4
101.6
134
43
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
71.7
100.7
115
17
TFP34
NOMESCO Finland
Electrophysiological investigation
212.9
98.4
101
5
R06.0
ICD-10 Finland
Dyspnoea
3.9
96.8
464
1445
ZXD05
NOMESCO Finland
Urgent procedure
3.2
95.9
641
2593
I20.09
ICD-10 Finland
Unstable angina
335.9
94.8
95
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
6.5
94.4
263
455
I20.99
ICD-10 Finland
Angina pectoris, unspecified
107.6
93.9
102
10
I44.1
ICD-10 Finland
Atrioventricular block, second degree
952.5
93.7
91
*
GD1LA
NOMESCO Finland
GD
128.9
91.8
98
8
TFJ02
NOMESCO Finland
Muscle biopsy of heart
+∞
90.3
86
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
+∞
89.2
85
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
162.6
88.9
93
6
A02BC02
ATC
pantoprazole; systemic
2.7
88.6
1209
7518
WX892
NOMESCO Finland
Monitored bed care
9.6
86.7
185
211
I25.2
ICD-10 Finland
Old myocardial infarction
441.4
85.7
85
*
I47.1
ICD-10 Finland
Supraventricular tachycardia
68.7
85.3
98
15
I40.8
ICD-10 Finland
Other acute myocarditis
+∞
85.0
81
*
K78
ICPC
Atrial fibrillation/flutter
44.3
84.8
105
25
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
84.5
423
1350
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
216.5
80.9
83
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
39.4
79.7
101
27
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
408.5
79.4
79
*
132
Kela drug reimbursment
Sarcoidosis
35.0
79.1
103
31
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
5.2
78.5
262
561
C08CA01
ATC
amlodipine; oral
3.3
78.4
473
1735
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
397.6
77.4
77
*
C07AA07
ATC
sotalol; systemic
22.6
77.0
113
53
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
392.2
76.3
76
*
L04AX01
ATC
azathioprine; systemic
7.6
75.9
187
269
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
72.9
73.8
84
12
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
7.9
71.6
171
234
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
+∞
71.3
68
*
I30.9
ICD-10 Finland
Acute pericarditis, unspecified
+∞
70.2
67
*
A12BA01
ATC
potassium chloride; oral
186.7
69.5
72
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
67.2
570
2579
FM1JR
NOMESCO Finland
Heart, extensive metabolic PET with CT
670.0
66.3
65
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
61.6
66.1
77
13
GEA00
NOMESCO Finland
Mediastinoscopy
65.8
65.9
76
12
XFE00
NOMESCO Finland
Epicardial ultrasonography
35.5
65.6
85
25
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
77.0
65.5
74
10
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
142.9
65.3
69
5
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
648.6
64.2
63
*
AP4
HP
Myocardial biopsy
+∞
63.9
61
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.6
63.8
241
583
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
62.5
424
1655
AA1AD
NOMESCO Finland
CT of head and brain
3.2
62.3
385
1409
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
6.0
60.9
177
318
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
+∞
58.6
56
*
WX872
NOMESCO Finland
Intensive care
12.8
58.4
106
87
C01BC04
ATC
flecainide; systemic
48.3
57.7
70
15
AS4
HP
Physiological pacemaker insertion DDD (R)
154.6
57.2
60
*
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
56.5
54
*
C09AA02
ATC
enalapril; systemic
3.9
56.5
254
721
C10AA01
ATC
simvastatin; oral
2.4
56.0
588
2944
M04AA01
ATC
allopurinol; systemic
4.5
55.0
208
501
C09DX04
ATC
valsartan and sacubitril; oral
+∞
54.4
52
*
I20.01
ICD-10 Finland
Unstable angina
+∞
54.4
52
*
4220A
ICD-9 Finland
Acute myocarditis in diseases classified elsewhere
+∞
54.4
52
*
C10AA05
ATC
atorvastatin; oral
2.5
54.1
519
2468
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
+∞
53.4
51
*
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
+∞
53.4
51
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.9
52.2
183
407
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
521.0
51.7
51
*
I49.3
ICD-10 Finland
Ventricular premature depolarization
5.6
50.6
156
300
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
73.1
50.3
57
8
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
+∞
50.2
48
*
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
50.2
48
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.2
50.0
294
1026
I35.0
ICD-10 Finland
Aortic (valve) stenosis
55.2
49.9
59
11
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.2
49.8
288
993
C07AG02
ATC
carvedilol; oral
13.1
49.2
88
70
L04AA06
ATC
mycophenolic acid; systemic
25.1
48.2
68
28
45499
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
+∞
48.1
46
*
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
+∞
48.1
46
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
47.6
638
3540
ZXE00
NOMESCO Finland
One hour or less
2.1
47.5
697
4027
I40.1
ICD-10 Finland
Isolated myocarditis
+∞
47.0
45
*
C03AA03
ATC
hydrochlorothiazide; oral
7.2
47.0
118
173
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
104.6
47.0
51
5
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
104.6
47.0
51
5
K84
ICPC
Heart disease other
33.1
46.6
61
19
C08CA02
ATC
felodipine; oral
7.3
46.1
115
167
I50
ICD-10 Finland
Heart failure
102.5
46.0
50
5
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
235.2
45.1
46
*
I49.5
ICD-10 Finland
Sick sinus syndrome
19.5
44.6
68
36
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
10.0
44.6
91
95
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
44.5
188
501
R4110
NOMESCO Finland
Physiotherapy
2.4
44.4
472
2332
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
73.0
44.2
50
7
AP1
HP
Catheterization of the left side of the heart
98.3
43.9
48
5
FPE37
NOMESCO Finland
Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
+∞
43.9
42
*
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
+∞
43.9
42
*
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
436.8
43.3
43
*
R07.3
ICD-10 Finland
Other chest pain
3.8
43.1
195
552
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
153.3
42.9
45
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.0
42.7
143
302
I20.00
ICD-10 Finland
Unstable angina
219.6
42.0
43
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
42.0
240
815
I20.90
ICD-10 Finland
Angina pectoris, unspecified
115.0
41.9
45
*
R50.9
ICD-10 Finland
Fever, unspecified
3.0
41.7
275
1029
Z2221
NOMESCO Finland
Medical doctor
2.3
41.6
494
2561
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
11.2
41.2
79
73
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
11.6
40.8
77
69
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
+∞
40.7
39
*
B01AB05
ATC
enoxaparin; parenteral
2.3
40.2
438
2176
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
+∞
39.7
38
*
103
Kela drug reimbursment
Diabetes, insulin-treated
2.5
39.7
358
1614
R55
ICD-10 Finland
Syncope and collapse
3.8
39.5
178
501
I44.0
ICD-10 Finland
Atrioventricular block, first degree
107.2
38.8
42
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
11.6
38.8
73
65
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
14.9
38.7
65
45
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
38.7
37
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
38.6
235
833
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
38.3
310
1313
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
8.7
38.2
84
100
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
384.4
38.1
38
*
C02EA02
ATC
NA
85.8
37.9
42
5
4549X
ICD-9 Finland
Varicose veins of lower extremities, Without mention of ulcer or inflammation
+∞
37.6
36
*
G47.3
ICD-10 Finland
Sleep apnoea
2.4
37.6
375
1774
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.1
37.4
153
395
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.7
37.3
111
204
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
37.1
468
2477
I25
ICD-10 Finland
Chronic ischaemic heart disease
26.1
36.8
51
20
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
+∞
36.6
35
*
AN4
HP
Balloon angioplasty and drug eluding stent
+∞
36.6
35
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
36.5
638
3854
C08DB01
ATC
diltiazem; oral
16.4
36.5
59
37
Z3231
NOMESCO Finland
Registered nurse
2.2
36.2
455
2400
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
5.3
36.0
114
226
R00.1
ICD-10 Finland
Bradycardia, unspecified
13.6
35.5
62
47
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
+∞
35.5
34
*
I34.1
ICD-10 Finland
Mitral (valve) prolapse
40.9
35.4
44
11
J01MA12
ATC
levofloxacin; systemic
2.4
35.2
327
1487
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
67.9
35.1
40
6
I42.8
ICD-10 Finland
Other cardiomyopathies
125.6
34.8
37
*
J01DB01
ATC
cefalexin; oral
1.9
34.7
1458
11906
I48.2
ICD-10 Finland
Chronic atrial fibrillation
+∞
34.5
33
*
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
+∞
34.5
33
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
+∞
34.5
33
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
33.8
1459
11957
AN2
HP
Balloon angioplasty, including several vessels
+∞
33.4
32
*
M05BA04
ATC
alendronic acid; oral
3.8
33.0
147
409
FL1AC
NOMESCO Finland
Left cardioangiography
172.8
32.8
34
*
AS8
HP
Physiological arrhythmia pacemaker insertionDDD (R) S
+∞
32.4
31
*
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
+∞
32.4
31
*
TK800
NOMESCO Finland
Hemodialysis
23.5
32.3
46
20
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
6.8
32.2
83
127
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
32.1
116
265
TFP35
NOMESCO Finland
Electroanatomical mapping
89.0
31.8
35
*
J01FA06
ATC
roxithromycin; oral
1.8
31.5
690
4471
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
25.8
31.0
43
17
A10BA02
ATC
metformin; oral
2.3
30.7
338
1661
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
+∞
30.3
29
*
5611
FHL
Vena saphena Magna and / or swarm of nodule and possible local emissions
+∞
30.3
29
*
B01AF01
ATC
rivaroxaban; oral
3.5
30.2
151
461
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
13.2
30.2
53
41
A02BC05
ATC
esomeprazole; systemic
1.8
30.0
674
4385
N02AX02
ATC
tramadol; systemic, rectal
1.8
29.9
677
4414
C08DA01
ATC
verapamil; systemic
7.1
29.9
74
107
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
83.9
29.8
33
*
AQ1
HP
Conventional electrophysiological examination
157.3
29.7
31
*
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
108.3
29.7
32
*
C09CA01
ATC
losartan; oral
2.3
29.7
305
1450
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.1
29.4
118
299
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
29.4
417
2290
XF640
NOMESCO Finland
NA
18.4
29.2
45
25
H02AB07
ATC
prednisone; oral
2.4
29.0
261
1159
Z94.1
ICD-10 Finland
Heart transplant status
295.9
28.8
29
*
I48.1
ICD-10 Finland
Persistent atrial fibrillation
295.9
28.8
29
*
C08CA13
ATC
lercanidipine; oral
3.7
28.8
133
381
B01AC24
ATC
ticagrelor; oral
152.1
28.7
30
*
J01FF01
ATC
clindamycin; systemic
2.0
28.5
452
2589
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
3.2
28.3
160
535
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
+∞
28.2
27
*
M10.9
ICD-10 Finland
Gout, unspecified
5.1
28.1
91
185
R03AC02
ATC
salbutamol; inhalant
1.7
28.1
857
6104
R42
ICD-10 Finland
Dizziness and giddiness
2.3
28.0
294
1408
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
28.0
289
1372
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.2
28.0
314
1554
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
64.9
28.0
32
5
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
28.0
142
439
T90
ICPC
Diabetes non-insulin dependent
2.3
27.9
284
1341
C09CA03
ATC
valsartan; oral
4.0
27.9
116
304
J01CA04
ATC
amoxicillin; systemic
1.8
27.8
1424
11835
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
43.1
27.8
34
8
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
27.6
759
5231
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
23.4
27.4
39
17
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.0
26.8
168
602
K77
ICPC
Heart failure
41.8
26.8
33
8
61
HP
Catheterization and pressure measurement of the left side of the heart
274.5
26.8
27
*
D86
ICD-10 Finland
Sarcoidosis
141.8
26.7
28
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.0
26.7
110
286
R00.2
ICD-10 Finland
Palpitations
3.6
26.5
123
354
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.8
26.3
116
320
C10AX09
ATC
ezetimibe; oral
3.7
26.1
119
337
82
HP
Single vessel balloon catheter extension
+∞
26.1
25
*
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
+∞
26.1
25
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
26.0
335
1756
A46
ICD-10 Finland
Erysipelas
2.6
25.9
209
871
I45.9
ICD-10 Finland
Conduction disorder, unspecified
263.7
25.7
26
*
127
Kela drug reimbursment
Transplant complication
17.7
25.7
40
23
SPAT1262
SPAT
Handing over of treatment supplies
2.3
25.7
249
1147
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
25.5
547
3462
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
25.4
265
1261
N05CF01
ATC
zopiclone; oral
1.8
25.4
504
3108
ZX120
NOMESCO Finland
Intravenous
3.0
25.3
157
560
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
+∞
25.0
24
*
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
+∞
25.0
24
*
AN3
HP
Balloon angioplasty and metallic stent
+∞
25.0
24
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.3
24.9
77
149
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
70.8
24.8
28
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.6
24.7
116
337
SPAT1097
SPAT
Recording of ECG
2.5
24.6
204
862
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.1
24.6
140
471
GD1AD
NOMESCO Finland
Thorax CT examination
4.7
24.5
85
187
R53
ICD-10 Finland
Malaise and fatigue
2.2
24.5
290
1465
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
18.8
24.4
37
20
N18.8
ICD-10 Finland
Other chronic renal failure
18.8
24.4
37
20
UJF32
NOMESCO Finland
Coloscopy
2.0
24.0
377
2130
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
+∞
24.0
23
*
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
24.0
23
*
J01AA02
ATC
doxycycline; systemic
1.7
24.0
1340
11111
N17.9
ICD-10 Finland
Acute renal failure, unspecified
7.7
23.9
56
75
C10AA03
ATC
pravastatin; oral
4.3
23.8
91
221
Z50.0
ICD-10 Finland
Cardiac rehabilitation
242.6
23.7
24
*
B33.2
ICD-10 Finland
Viral carditis
242.6
23.7
24
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
23.6
423
2509
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
126.5
23.6
25
*
C09AA04
ATC
perindopril; oral
5.2
23.4
74
147
S97
ICPC
Chronic ulcer skin
5.0
23.4
76
156
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
6.5
23.3
61
96
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
+∞
22.9
22
*
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
+∞
22.9
22
*
A02BC01
ATC
omeprazole; systemic
1.9
22.9
409
2419
XF409
NOMESCO Finland
Other special ECG
65.7
22.9
26
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
232.4
22.7
23
*
Z3226
NOMESCO Finland
Physiotherapist
2.1
22.6
283
1458
FPE40
NOMESCO Finland
Replacement of transvenous cardiac pacemaker electrode
121.3
22.6
24
*
C07AB03
ATC
atenolol; systemic
6.1
22.1
61
103
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.2
21.9
86
214
FPE96
NOMESCO Finland
Other implantation or replacement of transvenous cardiac pacemaker
+∞
21.9
21
*
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
63.2
21.9
25
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.5
21.8
184
785
K80
ICPC
Cardiac arrhythmia NOS
3.6
21.8
102
296
JN4DR
NOMESCO Finland
Whole body metabolic PET with CT
81.0
21.7
24
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
21.5
143
533
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
4.9
21.3
71
150
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.3
21.2
47
58
TGC00
NOMESCO Finland
Bronchial lavation
5.2
21.1
66
130
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
60.6
20.9
24
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.3
20.9
205
946
I21.00
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
20.9
20
*
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
+∞
20.9
20
*
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
24.5
20.8
29
12
J01DA01
ATC
[U] cefalexin; systemic
1.6
20.8
1039
8202
PD5BD
NOMESCO Finland
Extensive CT of aorta
21.7
20.8
30
14
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
37.6
20.8
26
7
A10AE04
ATC
insulin glargine; parenteral
3.1
20.8
120
408
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
20.6
737
5342
PHD76
NOMESCO Finland
Resection of long saphenous vein
9.5
20.6
42
45
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.7
20.6
71
156
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
13.7
20.5
35
26
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
20.5
327
1852
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
11.4
20.4
38
34
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
20.3
89
245
R00.0
ICD-10 Finland
Tachycardia, unspecified
4.4
20.1
73
169
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
6.6
20.1
52
81
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
20.1
85
227
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
20.0
309
1726
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
20.0
585
4009
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
19.0
20.0
30
16
J01MA02
ATC
ciprofloxacin; systemic
1.7
19.9
596
4110
J01MA14
ATC
moxifloxacin; systemic
2.7
19.9
145
572
C02AC05
ATC
moxonidine; oral
9.3
19.8
41
45
SPAT1263
SPAT
Sampling
1.6
19.8
623
4353
FPJ24
NOMESCO Finland
Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
+∞
19.8
19
*
A11
ICPC
Chest pain NOS
3.2
19.6
107
350
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
19.6
842
6368
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
201.8
19.6
20
*
C09DA01
ATC
losartan and diuretics; oral
3.1
19.5
112
379
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.3
19.4
60
117
B01AE07
ATC
dabigatran etexilate; oral
6.9
19.3
48
71
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
31.6
19.3
25
8
R03BB04
ATC
tiotropium bromide; inhalant
2.7
19.2
137
533
WX002
NOMESCO Finland
Sedation and analgesia
1.9
19.2
290
1607
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
18.9
101
326
R60.0
ICD-10 Finland
Localized oedema
2.6
18.8
141
562
AA1
HP
Conventional CABG
+∞
18.8
18
*
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
+∞
18.8
18
*
ASB
HP
Insertion of a biventricular physiological pacemaker DDD (R)
+∞
18.8
18
*
FPG40
NOMESCO Finland
Replacement of pulse generator in transvenous cardioverter-defibrillator
+∞
18.8
18
*
TFP40
NOMESCO Finland
Ablation treatment for a-v node re-entry activation
+∞
18.8
18
*
AP2
HP
Catheterization of the right side of the heart
+∞
18.8
18
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
70.5
18.7
21
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.5
18.7
148
612
K04
ICPC
Palpitations/awareness of heart
3.8
18.6
79
212
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
21.0
18.6
27
13
71
HP
Electrophysiological Special Examination
191.6
18.6
19
*
I40
ICD-10 Finland
Acute myocarditis
191.6
18.6
19
*
Z71.8
ICD-10 Finland
Other specified counselling
1.8
18.5
351
2104
R02
ICPC
Shortness of breath/dyspnoea
2.5
18.5
152
641
3AC01
NOMESCO Finland
NA
15.2
18.4
30
20
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
18.3
166
736
N02AA05
ATC
oxycodone; systemic
2.2
18.2
190
902
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
18.2
147
614
C10AA07
ATC
rosuvastatin; oral
1.9
18.1
289
1629
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
18.1
152
645
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
18.0
93
293
M79.6
ICD-10 Finland
Pain in limb
1.7
17.8
501
3378
A41.9
ICD-10 Finland
Sepsis, unspecified
4.9
17.7
58
121
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
67.2
17.7
20
*
R51.80
ICD-10 Finland
Headache
2.1
17.7
215
1090
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
17.7
325
1926
S18
ICPC
Laceration/cut
1.6
17.7
614
4373
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
17.6
168
762
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
12.6
17.6
31
25
N03AX16
ATC
pregabalin; oral
1.8
17.6
329
1961
B01AF03
ATC
edoxaban; oral
95.8
17.6
19
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.2
17.5
92
294
K29
ICPC
Cardiovascular sympt/complt other
4.7
17.3
59
129
C09AA01
ATC
captopril; oral
42.3
17.3
21
5
L04AD01
ATC
ciclosporin; systemic
6.2
17.1
46
76
WW200
NOMESCO Finland
Immunization
4.4
17.0
62
145
R04.0
ICD-10 Finland
Epistaxis
3.2
17.0
90
289
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
8.7
16.9
36
42
42798
ICD-8 Finland
Symptomatic heart disease, Alia arrhytmia definita
22.0
16.8
24
11
H02AB04
ATC
methylprednisolone; systemic
2.0
16.8
223
1173
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
16.7
135
563
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
16.7
116
445
342
Kela drug reimbursment
Dronedarone
+∞
16.7
16
*
I21.09
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
16.7
16
*
FPJ22
NOMESCO Finland
Revision of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
16.7
16
*
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
+∞
16.7
16
*
4130B
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]
+∞
16.7
16
*
11
HP
Coronary artery bypass surgery
+∞
16.7
16
*
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
35.3
16.7
21
6
R05
ICD-10 Finland
Cough
1.9
16.6
285
1647
N05BA04
ATC
oxazepam; oral
1.7
16.5
355
2209
A11CC03
ATC
alfacalcidol; systemic
13.5
16.5
28
21
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
20.2
16.4
24
12
A02BA02
ATC
ranitidine; systemic
1.9
16.4
277
1591
I45.0
ICD-10 Finland
Right fascicular block
40.4
16.3
20
5
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.0
16.3
96
332
R07.2
ICD-10 Finland
Precordial pain
6.5
16.3
42
66
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
6.3
16.2
43
70
N19
ICD-10 Finland
Unspecified kidney failure
6.9
16.2
40
59
C09BA02
ATC
enalapril and diuretics; systemic
4.0
16.2
64
162
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.0
16.2
65
167
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
30.3
16.1
21
7
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
30.3
16.1
21
7
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.7
16.0
114
443
I95.9
ICD-10 Finland
Hypotension, unspecified
18.7
16.0
24
13
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
15.9
627
4578
C07AB08
ATC
celiprolol; oral
14.6
15.8
26
18
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.6
15.8
55
123
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
60.5
15.8
18
*
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
60.5
15.8
18
*
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
7.4
15.7
37
51
E66.01
ICD-10 Finland
Obesity due to excess calories
3.0
15.7
92
318
I45.3
ICD-10 Finland
Trifascicular block
+∞
15.6
15
*
280
Kela drug reimbursment
Clopidogrel
+∞
15.6
15
*
40199
ICD-8 Finland
Essential benign hypertension
+∞
15.6
15
*
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
+∞
15.6
15
*
4120X
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]
+∞
15.6
15
*
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
+∞
15.6
15
*
AQ2
HP
Electrophysiological electroanatomical examination
+∞
15.6
15
*
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
+∞
15.6
15
*
SPAT1254
SPAT
Administration of medicine
2.1
15.5
180
894
1CX08
NOMESCO Finland
NA
161.1
15.5
16
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
161.1
15.5
16
*
C08CA05
ATC
nifedipine; systemic
3.5
15.5
73
215
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
15.4
127
535
A10AE05
ATC
insulin detemir; parenteral
3.6
15.4
71
205
N18.0
ICD-10 Finland
End-stage renal disease
38.3
15.4
19
5
A10BK01
ATC
dapagliflozin; oral
3.6
15.3
68
191
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
15.3
286
1698
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
15.1
108
420
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
15.0
558
4007
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
4.5
14.9
52
117
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
5.0
14.9
47
95
C09CA06
ATC
candesartan; oral
1.9
14.9
252
1445
A10BH01
ATC
sitagliptin; oral
2.7
14.7
100
379
72
HP
Catheter ablation of arrhythmia
+∞
14.6
14
*
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
+∞
14.6
14
*
I41.1*J11.8
ICD-10 Finland
Influenzal myocarditis (acute) virus not identified
+∞
14.6
14
*
J20
ICD-10 Finland
Acute bronchitis
2.2
14.5
145
673
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
14.5
70
211
Z2446
NOMESCO Finland
Social worker
2.6
14.4
105
414
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
14.4
255
1484
N06AX11
ATC
mirtazapine; oral
1.6
14.3
459
3174
A10BB12
ATC
glimepiride; oral
3.7
14.3
63
176
N06AB04
ATC
citalopram; systemic
1.7
14.3
305
1885
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.2
14.3
54
132
B01AC07
ATC
dipyridamole; systemic
5.6
14.2
41
75
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
14.0
113
472
N03AX12
ATC
gabapentin; oral
1.9
14.0
209
1143
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
14.0
70
217
M10
ICD-10 Finland
Gout
3.4
13.9
67
201
SPAT1325
SPAT
Vaccination
1.6
13.9
461
3213
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
53.7
13.8
16
*
K99
ICPC
Cardiovascular disease other
8.2
13.8
30
37
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
20.2
13.8
20
10
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.0
13.7
81
282
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.7
13.7
96
370
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
13.6
291
1800
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
14.8
13.6
22
15
FM1CN
NOMESCO Finland
Heart perfusion isotope imaging at rest
+∞
13.5
13
*
I30.0
ICD-10 Finland
Acute nonspecific idiopathic pericarditis
+∞
13.5
13
*
4270A
ICD-9 Finland
Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia
+∞
13.5
13
*
I44.3
ICD-10 Finland
Other and unspecified atrioventricular block
+∞
13.5
13
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
13.5
13
*
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
+∞
13.5
13
*
TFP47
NOMESCO Finland
Ablation or modification of the AV-node
+∞
13.5
13
*
E05.89
ICD-10 Finland
Other thyrotoxicosis
34.2
13.5
17
5
Z49.1
ICD-10 Finland
Extracorporeal dialysis
34.2
13.5
17
5
I95.1
ICD-10 Finland
Orthostatic hypotension
10.1
13.5
26
26
C01BA01
ATC
quinidine; oral
140.8
13.5
14
*
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
140.8
13.5
14
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
140.8
13.5
14
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
5.9
13.4
37
64
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
16.3
13.4
21
13
PHD99
NOMESCO Finland
Resection of other vein
4.0
13.4
53
135
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
13.4
427
2940
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
18.3
13.4
20
11
I49.1
ICD-10 Finland
Atrial premature depolarization
4.4
13.3
48
112
A10BK03
ATC
empagliflozin; oral
2.8
13.3
84
306
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
10.5
13.2
25
24
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.7
13.1
87
326
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
13.1
196
1076
A02BC03
ATC
lansoprazole; oral
1.6
13.1
406
2777
R03DC03
ATC
montelukast; oral
1.8
13.1
235
1373
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.8
13.0
32
48
WZC30
NOMESCO Finland
Teaching
1.9
12.9
182
978
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
12.9
169
882
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
7.7
12.9
29
38
SPAT1153
SPAT
Removal of sutures
1.5
12.7
446
3139
C09AA03
ATC
lisinopril; oral
5.0
12.6
40
82
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
15.5
12.6
20
13
XA800
NOMESCO Finland
Neuropsychological investigation
3.3
12.6
63
196
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
12.6
194
1078
E66.8
ICD-10 Finland
Other obesity
3.4
12.5
61
186
I21.11
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
12.5
12
*
63
HP
Cardiac muscle biopsy
+∞
12.5
12
*
250
Kela drug reimbursment
NA
+∞
12.5
12
*
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
+∞
12.5
12
*
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
+∞
12.5
12
*
FM1DM
NOMESCO Finland
Heart very extensive MRI examination with 3 Tesla magnet
+∞
12.5
12
*
TFP52
NOMESCO Finland
Ablation treatment of ventricular tachycardia due to structural heart defect
+∞
12.5
12
*
FN2AB
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon
+∞
12.5
12
*
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
+∞
12.5
12
*
I42
ICD-10 Finland
Cardiomyopathy
+∞
12.5
12
*
7AX01
NOMESCO Finland
NA
+∞
12.5
12
*
TFP32
NOMESCO Finland
Cathetric treatmen of cardiac arrythmia
+∞
12.5
12
*
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
+∞
12.5
12
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
12.5
109
476
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.6
12.5
56
160
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
12.5
72
247
TGD00
NOMESCO Finland
Needle biopsy of lung
20.1
12.4
18
9
WX740
NOMESCO Finland
Nitrogen oxide therapy
20.1
12.4
18
9
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
130.7
12.4
13
*
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
130.7
12.4
13
*
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
130.7
12.4
13
*
XFN00
NOMESCO Finland
Inside imaging of coronary arteries??
130.7
12.4
13
*
UKC02
NOMESCO Finland
Cystoscopy
1.9
12.4
205
1164
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
12.3
203
1152
R04.2
ICD-10 Finland
Haemoptysis
3.9
12.3
50
131
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.8
12.3
80
294
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
12.3
220
1286
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
12.2
364
2457
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
5.5
12.2
35
64
SPAT1301
SPAT
No procedures
1.6
12.2
412
2867
R20.2
ICD-10 Finland
Paraesthesia of skin
2.5
12.1
97
403
Y0399
ICD-8 Finland
Investigation of circulatory system
7.8
12.1
27
35
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
6.1
12.1
32
53
H03BB01
ATC
carbimazole; oral
3.3
12.0
59
181
ZX108
NOMESCO Finland
Inhalation
11.1
12.0
22
20
A10BH05
ATC
linagliptin; oral
4.0
12.0
47
120
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
5.2
12.0
36
70
M10.0
ICD-10 Finland
Idiopathic gout
4.4
11.9
42
97
H02AB09
ATC
hydrocortisone; systemic
4.2
11.8
44
107
FP1C5
NOMESCO Finland
Resting ECG, 15 leads
30.2
11.6
15
5
A28
ICPC
Limited function/disability NOS
2.1
11.6
137
686
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
11.6
125
600
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.9
11.6
28
41
I20.80
ICD-10 Finland
Other angina pectoris no detected stenosis of coronary artery
65.3
11.6
13
*
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
65.3
11.6
13
*
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
65.3
11.6
13
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.6
11.6
39
86
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.7
11.6
50
139
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
11.5
102
447
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.9
11.5
31
53
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
11.5
129
633
FN1BE
NOMESCO Finland
Ultrasound examination of coronary arteries through catheter
+∞
11.5
11
*
I20.10
ICD-10 Finland
Angina angiospastic
+∞
11.5
11
*
C01BD07
ATC
dronedarone; oral
+∞
11.5
11
*
AR6
HP
Catheter ablation of arrhythmia, target: atrial fibrillation
+∞
11.5
11
*
4120B
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]
+∞
11.5
11
*
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
+∞
11.5
11
*
4229A
ICD-9 Finland
Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA ALIA DEFINITA]
+∞
11.5
11
*
5612
FHL
Local excisions and / or perforations of relapsing varicose veins
+∞
11.5
11
*
I48.3
ICD-10 Finland
Typical atrial flutter
+∞
11.5
11
*
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
+∞
11.5
11
*
I21.19
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
11.5
11
*
C02LM02
ATC
NA
+∞
11.5
11
*
I45.2
ICD-10 Finland
Bifascicular block
+∞
11.5
11
*
I20.91
ICD-10 Finland
Angina pectoris, unspecified
+∞
11.5
11
*
73
HP
Initial pacemaker installation
120.6
11.4
12
*
I45.6
ICD-10 Finland
Pre-excitation syndrome
120.6
11.4
12
*
I25.8
ICD-10 Finland
Other forms of chronic ischaemic heart disease
120.6
11.4
12
*
WX402
NOMESCO Finland
General anaesthesia
1.7
11.4
227
1370
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
5.2
11.3
34
66
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
11.3
472
3444
R31
ICD-10 Finland
Unspecified haematuria
2.1
11.2
122
590
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
11.2
55
170
B01AB10
ATC
tinzaparin; parenteral
2.6
11.1
81
320
M13.9
ICD-10 Finland
Arthritis, unspecified
2.2
11.1
108
497
L28
ICPC
Limited function/disability (L)
1.9
11.1
162
882
WX722
NOMESCO Finland
PEEP
2.9
11.1
65
226
Z01.9
ICD-10 Finland
Special examination, unspecified
2.5
11.1
84
340
P01AB01
ATC
metronidazole; oral, rectal
1.5
11.0
554
4190
H53.4
ICD-10 Finland
Visual field defects
5.6
11.0
31
56
K90
ICPC
Stroke/cerebrovascular accident
10.1
11.0
21
21
B34.9
ICD-10 Finland
Viral infection, unspecified
3.4
11.0
51
151
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
43.5
10.9
13
*
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
43.5
10.9
13
*
SPAT1104
SPAT
Monitoring of emergency patient
2.5
10.9
84
345
FPW96
NOMESCO Finland
Other operation for arhythmia or disturbance of impulse propagation
28.1
10.7
14
5
C10AA04
ATC
fluvastatin; oral
2.5
10.7
85
354
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
10.6
142
747
R01AD09
ATC
mometasone; nasal
1.4
10.6
697
5539
E66.00
ICD-10 Finland
Metabolic syndrome
3.2
10.6
55
177
SPAT1229
SPAT
Assessment of need for aid
2.5
10.6
82
338
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.3
10.6
52
161
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.9
10.5
166
927
FN1AD
NOMESCO Finland
CT of coronary arteries
8.5
10.5
22
26
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
10.4
132
678
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
110.5
10.4
11
*
N16.2*D86.8
ICD-10 Finland
Renal tubulo-interstitial disorders in sarcoidosis
110.5
10.4
11
*
K83
ICPC
Heart valve disease NOS
110.5
10.4
11
*
WX902
NOMESCO Finland
External defibrillation of heart
+∞
10.4
10
*
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
+∞
10.4
10
*
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
+∞
10.4
10
*
5253
FHL
Cardiac lung machine
+∞
10.4
10
*
AP3
HP
Catheterization of the right and left side of the heart
+∞
10.4
10
*
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
+∞
10.4
10
*
I21.01
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
10.4
10
*
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
+∞
10.4
10
*
62
HP
Catheterization and pressure measurement of the right side of the heart
+∞
10.4
10
*
4271A
ICD-9 Finland
Cardiac dysrhythmias, Paroxysmal ventricular tachycardia
+∞
10.4
10
*
I41.8*M05.3
ICD-10 Finland
Rheumatoid myocarditis
+∞
10.4
10
*
4110X
ICD-9 Finland
Other acute and subacute forms of ischaemic heart disease, Postmyocardial infarction syndrome[EPÄSTABIILI ANGINA PECTORIS,MÄÄRITTELEMÄT]
+∞
10.4
10
*
41399
ICD-8 Finland
Angina pectoris, Without mention of hypertensive disease
+∞
10.4
10
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
+∞
10.4
10
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
10.4
78
316
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.1
10.4
110
528
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
4.5
10.4
35
78
M25.5
ICD-10 Finland
Pain in joint
1.5
10.3
407
2924
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
10.3
157
865
J01FA09
ATC
clarithromycin; systemic
1.5
10.3
487
3630
J01FA10
ATC
azithromycin; systemic
1.4
10.3
925
7746
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
10.3
100
462
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
10.3
394
2812
E87.5
ICD-10 Finland
Hyperkalaemia
8.8
10.3
21
24
TK810
NOMESCO Finland
Hemofiltration
18.9
10.3
15
8
R03AC03
ATC
terbutaline; inhalant
1.8
10.2
197
1175
R05FB02
ATC
cough suppressants and expectorants
1.4
10.2
533
4051
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
10.2
297
1990
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.9
10.2
41
108
M54.5
ICD-10 Finland
Low back pain
1.5
10.2
459
3390
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.2
10.1
30
58
R11
ICD-10 Finland
Nausea and vomiting
2.3
10.1
90
397
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.4
10.1
48
145
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.8
10.1
41
109
G04BE03
ATC
sildenafil; oral
4.8
10.1
32
67
K02
ICPC
Pressure/tightness of heart
4.8
10.1
32
67
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
10.1
123
625
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
6.1
10.0
26
43
C08CA07
ATC
nisoldipine; oral
40.2
10.0
12
*
SPAT1255
SPAT
Intravenous administration of medicine
2.5
9.9
78
325
C02DE04
ATC
NA
26.1
9.8
13
5
R52.9
ICD-10 Finland
Pain, unspecified
2.1
9.8
112
553
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.3
9.8
88
391
JN4BD
NOMESCO Finland
Extensive body CT
1.9
9.8
143
779
R03AK08
ATC
formoterol and beclometasone; inhalant
2.8
9.7
61
222
R03DA04
ATC
theophylline; systemic, rectal
2.5
9.7
72
290
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
55.2
9.6
11
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
9.6
155
872
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
9.6
389
2804
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
9.6
81
348
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
9.6
306
2091
A10BB01
ATC
glibenclamide; oral
4.9
9.6
30
62
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.8
9.6
58
208
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
9.6
57
202
R03AC12
ATC
salmeterol; inhalant
2.6
9.6
66
256
WX110
NOMESCO Finland
Local anesthesy
1.4
9.5
1110
9648
ZXD00
NOMESCO Finland
Emergency procedure
3.4
9.5
44
131
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
9.4
208
1294
FM1TQ
NOMESCO Finland
Heart perfusion SPECT with low dose CT at rest and with exercise
100.4
9.4
10
*
I47.0
ICD-10 Finland
Re-entry ventricular arrhythmia
100.4
9.4
10
*
C09CA07
ATC
telmisartan; oral
2.5
9.4
72
296
R60.9
ICD-10 Finland
Oedema, unspecified
3.0
9.4
54
186
ZXA10
NOMESCO Finland
Bilateral
1.6
9.4
229
1463
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
+∞
9.4
9
*
FPJ00
NOMESCO Finland
Revision of pacemaker pulse generator or electrode
+∞
9.4
9
*
74
HP
Initial installation of the atrial pacemaker
+∞
9.4
9
*
I20.19
ICD-10 Finland
Angina angiospastic
+∞
9.4
9
*
5315
FHL
Bypass surgery using a mammary artery
+∞
9.4
9
*
I71.09
ICD-10 Finland
Aortic dissection [regardless of location]
+∞
9.4
9
*
PEN23
NOMESCO Finland
Plastic repair of femoral artery
+∞
9.4
9
*
AB1
HP
AVR mechanical
+∞
9.4
9
*
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
+∞
9.4
9
*
FN1CA
NOMESCO Finland
Optical coherence tomography of coronary arteries
+∞
9.4
9
*
FJA00
NOMESCO Finland
Biopsy of right ventricle
+∞
9.4
9
*
TFN04
NOMESCO Finland
NA
+∞
9.4
9
*
4111X
ICD-9 Finland
Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]
+∞
9.4
9
*
I21.10
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
9.4
9
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
9.4
90
411
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
21.8
9.3
13
6
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.0
9.3
36
92
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.4
9.3
44
133
H26.02
ICD-10 Finland
Presenil cataract
3.4
9.3
44
133
E0000UV
ATC
NA
1.4
9.3
559
4349
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.1
9.2
34
83
N05AH04
ATC
quetiapine; oral
1.6
9.2
237
1537
J46
ICD-10 Finland
Status asthmaticus
3.9
9.2
36
93
C09DA03
ATC
valsartan and diuretics; oral
3.8
9.2
37
98
C07AB05
ATC
betaxolol; oral
6.7
9.1
22
33
XF602
NOMESCO Finland
Bloodpressure monitoring
15.6
9.0
14
9
C07AB04
ATC
acebutolol; systemic
15.6
9.0
14
9
K05
ICPC
Irregular heartbeat other
4.4
9.0
31
71
R03BA02
ATC
budesonide; inhalant
1.6
9.0
248
1635
R06.4
ICD-10 Finland
Hyperventilation
4.5
9.0
30
67
M01AE02
ATC
naproxen; oral, rectal
1.3
8.9
891
7525
I20.0
ICD-10 Finland
Unstable angina
24.1
8.9
12
5
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
24.1
8.9
12
5
N05CD07
ATC
temazepam; oral
1.8
8.9
154
888
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
8.9
573
4510
A06AD11
ATC
lactulose; oral
1.8
8.8
166
984
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
8.8
106
538
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
10.7
8.8
16
15
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
5.1
8.8
26
51
A10BJ02
ATC
liraglutide; parenteral
5.4
8.7
25
47
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.6
8.7
38
108
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
8.7
233
1524
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
8.7
50
172
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.1
8.7
45
146
I51.9
ICD-10 Finland
Heart disease, unspecified
50.2
8.7
10
*
PD5CD
NOMESCO Finland
Very extensive CT angiography of aorta
50.2
8.7
10
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.5
8.7
67
278
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
8.6
108
555
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.5
8.6
66
271
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.7
8.6
36
99
G04BE01
ATC
alprostadil; parenteral, urethral
4.2
8.6
31
75
R2110
NOMESCO Finland
Giving the first information
2.2
8.5
83
385
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
8.5
105
535
R03BA05
ATC
fluticasone; inhalant
1.6
8.5
249
1667
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
8.5
51
183
J96.1
ICD-10 Finland
Chronic respiratory failure
5.1
8.5
25
49
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
8.4
91
439
G44.2
ICD-10 Finland
Tension-type headache
1.7
8.4
162
967
C02EA01
ATC
NA
90.3
8.4
9
*
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
90.3
8.4
9
*
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
90.3
8.4
9
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
8.4
86
408
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
12.8
8.4
14
11
K01
ICPC
Heart pain
6.7
8.4
20
30
I21.4
ICD-10 Finland
Acute subendocardial myocardial infarction
+∞
8.3
8
*
FN2CA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure
+∞
8.3
8
*
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
8.3
8
*
I71.00
ICD-10 Finland
Dissecting aneurysm of aorta (ruptured) [any part]
+∞
8.3
8
*
4140B
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]
+∞
8.3
8
*
AC2
HP
MVR bio
+∞
8.3
8
*
I51.8
ICD-10 Finland
Other ill-defined heart diseases
+∞
8.3
8
*
I70.1
ICD-10 Finland
Atherosclerosis of renal artery
+∞
8.3
8
*
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
+∞
8.3
8
*
FXE00
NOMESCO Finland
Use of ECLA
+∞
8.3
8
*
FPJ21
NOMESCO Finland
Revision of cardioverter-defibrillator with ventricular electrode
+∞
8.3
8
*
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
+∞
8.3
8
*
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
+∞
8.3
8
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
+∞
8.3
8
*
4254A
ICD-9 Finland
Cardiomyopathy, Other primary cardiomyopathies
+∞
8.3
8
*
FN1XT
NOMESCO Finland
Other coronary artery procedure through catheter
+∞
8.3
8
*
C07FB02
ATC
metoprolol and felodipine; systemic
6.2
8.3
21
34
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
6.2
8.3
21
34
R4140
NOMESCO Finland
Psychotherapy
8.6
8.3
17
20
SPAT1216
SPAT
Assessment of functional ability
1.7
8.3
159
947
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.5
8.3
37
108
PD5AD
NOMESCO Finland
CT of aorta
9.5
8.3
16
17
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
8.3
198
1260
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.2
8.2
29
69
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.0
8.2
105
547
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
8.2
132
746
E66.9
ICD-10 Finland
Obesity, unspecified
3.7
8.1
34
94
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.4
8.1
37
110
-
ICD-10 Finland
NA
3.4
8.1
37
110
I06.9
ICD-10 Finland
Rheumatic aortic valve disease, unspecified
33.4
8.1
10
*
Q23.11
ICD-10 Finland
Bicuspid aortic valve
33.4
8.1
10
*
ZYC01
NOMESCO Finland
Remote contact by phone
2.4
8.1
63
263
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.0
8.1
30
75
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
8.0
89
438
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
8.0
99
506
XF620
NOMESCO Finland
Examination of circulation with color method
22.1
8.0
11
5
ANC
HP
Coronary artery pressure measurement (FFR, fractional flow reserve)
22.1
8.0
11
5
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
22.1
8.0
11
5
I45.1
ICD-10 Finland
Other and unspecified right bundle-branch block
22.1
8.0
11
5
WX320
NOMESCO Finland
Spinalanesthesy
1.5
8.0
288
2021
B03XA02
ATC
darbepoetin alfa; parenteral
6.3
8.0
20
32
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.7
8.0
51
190
SPAT1081
SPAT
Cardiorespiratory global assessment
2.6
7.9
55
215
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
7.9
73
330
A08
ICPC
Swelling
3.1
7.9
41
134
I20.9
ICD-10 Finland
Angina pectoris, unspecified
13.1
7.9
13
10
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
7.8
7.9
17
22
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
5.7
7.8
21
37
A04
ICPC
Weakness/tiredness general
1.8
7.8
141
828
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.7
527
4163
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
45.1
7.7
9
*
FPJ04
NOMESCO Finland
Revision of pacemaker generator with atrial and ventricular electrodes
45.1
7.7
9
*
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
45.1
7.7
9
*
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.7
405
3061
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.1
7.7
28
69
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.4
7.6
61
259
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
7.6
160
982
N06AB06
ATC
sertraline; oral
1.7
7.6
148
888
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.1
7.6
39
127
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
25.1
7.6
10
*
C09DA06
ATC
candesartan and diuretics; oral
2.5
7.6
54
216
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.9
7.5
29
75
H26.3
ICD-10 Finland
Drug-induced cataract
8.9
7.5
15
17
SPAT1252
SPAT
Overall medication plan or its review
2.3
7.5
68
306
A41.8
ICD-10 Finland
Other specified sepsis
5.4
7.5
21
39
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
7.5
384
2885
H03AA01
ATC
levothyroxine sodium; systemic
1.5
7.5
276
1946
TAB00
NOMESCO Finland
Lumbar puncture
2.2
7.5
68
308
AS2
HP
Ventricular pacemaker insertion VVI (R)
80.3
7.4
8
*
M10.3
ICD-10 Finland
Gout due to impairment of renal function
80.3
7.4
8
*
I20.8
ICD-10 Finland
Other forms of angina pectoris
80.3
7.4
8
*
J01FA01
ATC
erythromycin; systemic
1.6
7.4
207
1369
N06AA09
ATC
amitriptyline; systemic
1.8
7.4
118
666
J45
ICD-10 Finland
Asthma
1.8
7.4
127
734
P01BA02
ATC
hydroxychloroquine; oral
1.9
7.4
106
575
J01DA06
ATC
[U] cefuroxime; systemic
1.6
7.4
208
1378
N17.8
ICD-10 Finland
Other acute renal failure
8.4
7.3
15
18
R94.3
ICD-10 Finland
Abnormal results of cardiovascular function studies
8.4
7.3
15
18
M48.0
ICD-10 Finland
Spinal stenosis
1.8
7.3
117
660
FPG04
NOMESCO Finland
Insertion of internal defibrillator, atrial and chamber electrode
+∞
7.3
7
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
7.3
7
*
PC1BD
NOMESCO Finland
Extensive CT of thoracic aorta
+∞
7.3
7
*
PE1AT
NOMESCO Finland
Femoral artery PTA
+∞
7.3
7
*
FCA50
NOMESCO Finland
Resection and reconstruction of ascending aorta using tube graft
+∞
7.3
7
*
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
+∞
7.3
7
*
FPB22
NOMESCO Finland
Transvenous radiofrequency ablation of aberrant pathway or focus of heart
+∞
7.3
7
*
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
+∞
7.3
7
*
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
7.3
7
*
4209X
ICD-9 Finland
Acute pericarditis, Other and unspecified acute pericarditis[PERICARDITIS ALIA DEFINITA SEU NUD]
+∞
7.3
7
*
AK1
HP
HTX (heart transplant)
+∞
7.3
7
*
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
+∞
7.3
7
*
111
HP
Conventional CABG
+∞
7.3
7
*
I27.0
ICD-10 Finland
Primary pulmonary hypertension
+∞
7.3
7
*
5314
FHL
Bypass surgery for four or more vessels
+∞
7.3
7
*
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
+∞
7.3
7
*
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
+∞
7.3
7
*
I95.8
ICD-10 Finland
Other hypotension
+∞
7.3
7
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
+∞
7.3
7
*
I41.0
ICD-10 Finland
Myocarditis in bacterial diseases classified elsewhere
+∞
7.3
7
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
7.3
94
492
WX890
NOMESCO Finland
Intesive care monitoring
10.9
7.3
13
12
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
7.3
131
766
D07AC01
ATC
betamethasone; topical
1.4
7.3
464
3625
K92.1
ICD-10 Finland
Melaena
2.6
7.2
51
202
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.4
7.2
20
37
K28
ICPC
Limited function/disability (K)
5.8
7.2
19
33
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
5.8
7.2
19
33
A07AA02
ATC
nystatin; oral
2.1
7.2
75
358
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
7.2
78
382
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.2
516
4106
Z94.0
ICD-10 Finland
Kidney transplant status
30.1
7.1
9
*
ATX
HP
Other pacemaker replacement or related action, such as cord removal or replacement
30.1
7.1
9
*
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
30.1
7.1
9
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
20.1
7.1
10
5
R06AE07
ATC
cetirizine; oral
1.3
7.1
630
5171
SPAT1211
SPAT
Application of soft bandage
1.9
7.1
104
567
ZXA00
NOMESCO Finland
Right side
1.4
7.1
339
2514
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
7.9
7.1
15
19
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.1
262
1848
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.9
7.1
39
134
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
12.1
7.1
12
10
S22.3
ICD-10 Finland
Fracture of rib
2.0
7.1
88
455
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.9
7.1
27
70
R06.2
ICD-10 Finland
Wheezing
2.5
7.0
53
218
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
7.0
151
934
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
10.0
7.0
13
13
N03AX14
ATC
levetiracetam; systemic
3.2
7.0
34
107
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.5
7.0
30
86
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.9
7.0
40
139
C09DB01
ATC
valsartan and amlodipine; oral
3.6
7.0
29
81
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.4
6.9
58
250
UJF92
NOMESCO Finland
Capsular endoscopy
3.4
6.9
31
92
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
6.9
268
1910
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
13.8
6.9
11
8
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
4.1
6.9
25
62
C07BB07
ATC
bisoprolol and thiazides; systemic
3.7
6.9
28
77
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
6.9
124
728
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
6.9
154
964
79199
ICD-8 Finland
Headache
4.8
6.8
21
44
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
6.8
127
751
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
6.8
124
731
AA5PD
NOMESCO Finland
CT examination of brain pefusion
11.0
6.8
12
11
D72.1
ICD-10 Finland
Eosinophilia
11.0
6.8
12
11
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
11.0
6.8
12
11
M81.4
ICD-10 Finland
Drug-induced osteoporosis
9.3
6.8
13
14
WX213
NOMESCO Finland
Lower leg blockade
9.3
6.8
13
14
NHQ40
NOMESCO Finland
Amputation of toe
9.3
6.8
13
14
C02CA01
ATC
prazosin; oral
9.3
6.8
13
14
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
6.8
150
935
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
6.8
229
1584
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.3
6.8
19
36
E11.09
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - With coma
40.1
6.8
8
*
3A064
NOMESCO Finland
NA
40.1
6.8
8
*
XPX08
NOMESCO Finland
Intraoperative flow measurement
40.1
6.8
8
*
K29.7
ICD-10 Finland
Gastritis, unspecified
2.6
6.8
45
174
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
6.7
137
835
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
16.7
6.7
10
6
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.3
6.7
23
54
XW000
NOMESCO Finland
Bone marrow biopsy
2.5
6.7
48
193
A10BX07
ATC
[U] liraglutide; parenteral
7.2
6.7
15
21
C08CA10
ATC
nilvadipine; oral
7.2
6.7
15
21
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
6.7
360
2726
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.7
149
930
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.1
6.7
74
365
K93
ICPC
Pulmonary embolism
22.6
6.7
9
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.4
6.6
22
50
R03BA08
ATC
ciclesonide; inhalant
1.8
6.6
104
582
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
6.6
76
380
E66.0
ICD-10 Finland
Obesity due to excess calories
7.8
6.6
14
18
A40.8
ICD-10 Finland
Other streptococcal sepsis
7.8
6.6
14
18
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.9
6.6
17
29
R01AD08
ATC
fluticasone; nasal
1.4
6.6
414
3217
TQW80
NOMESCO Finland
Local dermatologic skincare
2.9
6.6
36
124
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.3
6.6
56
246
D09
ICPC
Nausea
2.4
6.6
51
215
B01AB04
ATC
dalteparin; parenteral
2.6
6.6
46
181
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
6.5
423
3302
N30.0
ICD-10 Finland
Acute cystitis
1.7
6.5
123
733
212
Kela drug reimbursment
Gout
4.8
6.5
20
42
J05AB01
ATC
aciclovir; systemic
1.4
6.5
279
2024
R05
ICPC
Cough
1.4
6.5
279
2024
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
6.5
200
1354
WX730
NOMESCO Finland
Conventional respirator
5.0
6.5
19
38
D07AC13
ATC
mometasone; topical
1.4
6.5
404
3136
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
6.5
81
419
J05AB11
ATC
valaciclovir; oral
1.6
6.4
176
1157
L89
ICD-10 Finland
Decubitus ulcer and pressure area
5.7
6.4
17
30
WX720
NOMESCO Finland
Own respiration
2.8
6.4
39
143
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.4
6.4
29
87
TFP59
NOMESCO Finland
Ablation treatment of other ventricular tachycardia
70.0
6.4
7
*
WX930
NOMESCO Finland
Thepapeutic hypothermia
70.0
6.4
7
*
I63.8
ICD-10 Finland
Other cerebral infarction
70.0
6.4
7
*
I42.5
ICD-10 Finland
Other restrictive cardiomyopathy
70.0
6.4
7
*
FM1CD
NOMESCO Finland
Very extensive CT of heart
70.0
6.4
7
*
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
70.0
6.4
7
*
C01BB02
ATC
mexiletine; systemic
70.0
6.4
7
*
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
70.0
6.4
7
*
Z71.9
ICD-10 Finland
Counselling, unspecified
2.1
6.4
70
344
J45.8
ICD-10 Finland
Mixed asthma
2.9
6.4
37
130
R03BA01
ATC
beclometasone; inhalant
1.5
6.4
183
1221
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.6
6.4
26
72
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.9
6.4
24
62
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.9
6.3
19
39
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
6.3
155
990
J01EA01
ATC
trimethoprim; systemic
1.4
6.3
266
1921
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.7
6.3
119
709
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
4.2
6.3
22
53
N05BA01
ATC
diazepam; systemic, rectal
1.6
6.3
164
1068
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.0
6.3
16
27
XF405
NOMESCO Finland
Symptom ECG
9.3
6.3
12
13
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
6.3
117
694
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
6.3
1126
10104
GD2SN
NOMESCO Finland
Lung ventilation SPECT
18.1
6.3
9
5
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
18.1
6.3
9
5
I97.0
ICD-10 Finland
Postcardiotomy syndrome
+∞
6.2
6
*
FNE20
NOMESCO Finland
Coronary bypass using free arterial graft of radial artery
+∞
6.2
6
*
T82.7
ICD-10 Finland
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts
+∞
6.2
6
*
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
+∞
6.2
6
*
C01BC03
ATC
propafenone; systemic
+∞
6.2
6
*
AT8
HP
Physiological pacemaker replacement DDD (R) S
+∞
6.2
6
*
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
+∞
6.2
6
*
41397
ICD-8 Finland
Angina pectoris, Suspecta, hypertonia non indicata
+∞
6.2
6
*
AR1
HP
Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)
+∞
6.2
6
*
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
+∞
6.2
6
*
3A149
NOMESCO Finland
NA
+∞
6.2
6
*
FM1BG
NOMESCO Finland
MRI examination of heart with high intensity magnet
+∞
6.2
6
*
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
+∞
6.2
6
*
4140X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]
+∞
6.2
6
*
I41.1*J09
ICD-10 Finland
Myocarditis in influenza caused by certain identified influenza viruses
+∞
6.2
6
*
XFP02
NOMESCO Finland
NA
+∞
6.2
6
*
41099
ICD-8 Finland
Acute myocardial infarction, Without mention of hypertensive disease
+∞
6.2
6
*
AT4
HP
Physiological pacemaker replacement DDD (R)
+∞
6.2
6
*
AS6
HP
Biventricular physiological heart failure pacemaker insertion DDD (R)
+∞
6.2
6
*
FN2AA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), balloon only
+∞
6.2
6
*
83
HP
Multi-vessel balloon catheter extension
+∞
6.2
6
*
I41.1
ICD-10 Finland
Myocarditis in viral diseases classified elsewhere
+∞
6.2
6
*
40299
ICD-8 Finland
Hypertensive heart disease
+∞
6.2
6
*
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
+∞
6.2
6
*
I41.0*A18.8
ICD-10 Finland
Tuberculosis of myocardium
+∞
6.2
6
*
AC4
HP
MVP
+∞
6.2
6
*
A02BA03
ATC
famotidine; systemic
2.4
6.2
48
201
GD1UN
NOMESCO Finland
Lung circulation SPECT
26.7
6.2
8
*
K50
ICPC
Cardiovascular, Medication/prescr/renewal
26.7
6.2
8
*
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
26.7
6.2
8
*
J94.8
ICD-10 Finland
Other specified pleural conditions
4.3
6.2
21
49
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
7.0
6.2
14
20
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
7.0
6.2
14
20
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
6.2
106
614
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
6.2
61
286
WZA90
NOMESCO Finland
Other doctors statement
1.4
6.2
312
2334
L04AA01
ATC
[U] ciclosporin; systemic
4.5
6.2
20
45
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.3
6.1
28
85
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.0
6.1
33
113
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
7.7
6.1
13
17
K30
ICD-10 Finland
Functional dyspepsia
1.7
6.1
124
755
ZY010
NOMESCO Finland
Hospital outpatient
2.1
6.1
65
316
N03AF01
ATC
carbamazepine; oral, rectal
2.1
6.1
65
317
SPAT1312
SPAT
General health counselling
1.3
6.1
423
3340
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
6.0
76
396
160
Kela drug reimbursment
exenatide
4.9
6.0
18
37
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
2.9
6.0
35
124
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
10.0
6.0
11
11
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
6.0
101
582
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
405
432
11.35
307.65
7.0
1.8
ng/l
196.3
53.1
12.41
375
369
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1172
3957
5.39
307.65
8.3
1.9
ng/l
162.0
22.2
0.62
931
2165
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
444
517
10.60
307.65
7.1
1.8
u/l
36.3
42.1
5.30
411
483
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
205
49
46.19
307.65
8.5
2.3
u/ml
492.8
832.4
1.71
205
49
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1045
1806
10.45
307.65
9.1
1.5
ng/l
1139.4
338.0
13.93
956
1356
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
696
1715
5.55
277.21
10.5
2.1
ng/l
364.6
227.8
0.49
594
1070
(3032080) INR in Blood by Coagulation assay
1056
3816
4.52
257.29
14.8
2.8
inr
1.3
1.1
13.60
313
1056
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
322
499
7.43
203.58
3.2
1.5
ug/l
16.8
4.3
3.94
287
419
(3018677) aPTT in Platelet poor plasma by Coagulation assay
453
1143
4.77
168.40
4.6
1.6
s
30.5
28.9
5.10
445
1101
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
446
1128
4.74
165.11
3.0
1.6
%
23.0
26.6
5.39
415
974
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1190
5909
3.31
158.96
10.6
4.6
mmol/l
1.2
1.2
6.04
1023
4978
(3022217) INR in Platelet poor plasma by Coagulation assay
371
840
5.14
156.59
34.0
3.5
inr
1.7
1.1
5.45
40
167
(3022948) Iron [Moles/volume] in Serum or Plasma
485
1367
4.30
155.41
2.9
1.6
umol/l
13.2
15.6
9.13
466
1255
(3004789) Transferrin [Mass/volume] in Serum or Plasma
457
1253
4.37
151.66
2.9
1.6
g/l
2.3
2.4
1.89
440
1158
(3023368) Bacteria identified in Blood by Culture
721
2715
3.51
150.77
4.9
3.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
506
1506
4.10
150.11
6.7
3.3
mmol/l
0.8
0.8
2.86
484
1392
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
131
88
15.79
149.54
6.1
2.1
u/ml
0.3
0.2
1.87
78
34
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1093
5301
3.19
149.36
9.8
4.1
mmol/l
1.2
1.2
9.27
1037
4727
(3020779) Urea [Moles/volume] in Serum or Plasma
308
619
5.65
148.48
14.2
4.1
mmol/l
11.2
7.4
10.72
293
594
(3013826) Glucose [Moles/volume] in Serum or Plasma
1305
7150
3.15
141.39
8.1
3.2
mmol/l
6.7
6.5
2.18
1255
6558
(3006315) Basophils [#/volume] in Blood
1279
6961
3.11
139.60
10.5
5.7
e9/l
0.0
0.0
0.31
1154
6005
(3001604) Monocytes [#/volume] in Blood
1274
6920
3.11
139.53
10.5
5.7
e9/l
0.6
0.6
8.79
1146
5974
(3018418) pH of Serum or Plasma
798
3358
3.21
136.87
5.5
2.9
ph
7.4
7.4
0.63
162
569
(42870588) Differential panel, method unspecified - Blood
956
4478
3.07
135.64
10.3
5.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1226
6649
3.00
132.20
7.9
5.7
umol/l
12.5
11.2
2.45
1173
6297
(3019198) Lymphocytes [#/volume] in Blood
1293
7221
3.03
132.06
10.5
5.7
e9/l
1.8
2.0
3.66
1180
6345
(3013115) Eosinophils [#/volume] in Blood
1295
7241
3.03
131.92
11.0
5.9
e9/l
0.2
0.2
0.16
1173
6317
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
631
2387
3.34
128.19
3.2
1.5
mg/l
1.4
0.8
1.48
484
1720
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
475
1500
3.79
127.81
2.0
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
346
898
4.41
121.87
12.7
6.7
kpa
5.0
5.1
1.44
326
853
(3027801) Oxygen [Partial pressure] in Arterial blood
346
898
4.41
121.87
12.7
6.7
kpa
11.4
13.4
9.72
327
859
(3016502) Oxygen saturation in Arterial blood
317
770
4.66
121.50
13.4
7.3
%
95.7
96.5
1.71
303
740
(3013650) Neutrophils [#/volume] in Blood by Automated count
1376
8182
2.95
120.93
12.9
8.8
e9/l
4.2
3.8
5.06
1251
7088
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
742
3181
3.05
120.61
2.8
1.8
u/l
181.2
262.2
1.10
708
2963
(3003396) Base excess in Arterial blood by calculation
340
892
4.35
117.89
12.7
6.7
mmol/l
0.9
0.8
0.22
269
686
(3006504) Eosinophils/100 leukocytes in Blood
1168
6502
2.78
114.22
10.9
5.8
%
3.0
3.0
0.20
1134
6017
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
353
978
4.13
113.55
1.9
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
285
672
4.74
113.03
11.5
1.4
mg/l
3.1
3.6
0.39
272
437
(3022096) Basophils/100 leukocytes in Blood
1140
6294
2.76
112.89
11.0
5.8
%
0.7
0.7
0.54
1108
5832
(3019069) Monocytes/100 leukocytes in Blood
1170
6567
2.75
111.77
11.2
6.0
%
8.9
8.6
3.78
1140
6101
(3027456) Digoxin [Moles/volume] in Serum or Plasma
65
14
47.84
111.02
2.5
1.7
nmol/l
0.9
1.0
—
41
6
(3036481) Cortisol [Moles/volume] in Serum or Plasma
343
951
4.11
110.05
2.3
2.1
nmol/l
357.7
372.5
0.59
324
881
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
350
991
4.03
109.03
2.0
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
371
1099
3.88
108.37
12.9
6.1
mmol/l
104.3
104.4
0.16
365
1078
(3018010) Neutrophils/100 leukocytes in Blood
1184
6762
2.70
108.00
10.6
5.6
%
58.5
55.7
14.58
1146
6291
(3002173) Hemoglobin [Mass/volume] in Arterial blood
290
720
4.51
107.61
14.1
7.7
g/l
126.2
126.3
0.01
280
688
(3002030) Lymphocytes/100 leukocytes in Blood
1192
6840
2.70
107.53
10.9
5.7
%
26.3
29.7
24.21
1156
6328
(3000991) Gas panel - Venous blood
268
672
4.42
97.86
17.5
6.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
277
733
4.19
94.07
5.8
2.6
kpa
5.8
5.9
0.10
263
710
(3003458) Phosphate [Moles/volume] in Serum or Plasma
357
1128
3.60
94.03
7.5
3.5
mmol/l
1.1
1.0
6.11
345
1048
(3002032) Base excess in Venous blood by calculation
273
737
4.10
90.09
5.8
2.5
mmol/l
2.0
2.0
0.00
223
595
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
136
200
7.19
88.73
1.5
1.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
272
743
4.05
88.25
15.8
5.9
mmol/l
1.4
1.4
0.04
262
717
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
578
2516
2.78
87.21
2.5
1.8
mg/l
3.1
2.7
2.63
506
2085
(3021589) Normoblasts [#/volume] in Blood
1072
6303
2.42
85.09
14.6
7.3
e9/l
0.0
0.0
0.41
910
5139
(3019060) Gas panel - Arterial blood
205
475
4.67
82.34
3.9
5.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
937
5255
2.40
81.91
5.7
3.9
g/l
35.4
36.8
9.47
881
4821
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
131
205
6.74
80.59
1.5
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
231
614
4.10
77.50
5.3
2.4
kpa
4.5
4.7
0.35
218
592
(3036489) Thrombin time
136
231
6.22
77.19
4.8
1.8
s
24.5
20.5
2.72
128
199
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
326
1099
3.32
76.70
5.6
4.8
u/l
272.0
235.3
3.44
314
1035
(3044889) 12 lead EKG panel
1472
10240
2.43
75.87
6.8
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
940
5421
2.32
75.38
4.9
2.3
ug/l
140.6
134.8
0.27
900
5023
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
144
268
5.69
74.31
5.0
1.8
ug/l
643.9
514.2
0.20
139
246
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1552
11233
2.43
70.21
10.5
6.1
u/l
75.6
75.7
0.03
1497
10468
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
103
145
7.41
69.75
1.5
2.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
175
413
4.53
68.45
19.0
9.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
147
305
5.10
67.15
1.9
1.6
g/l
1.5
1.4
0.35
126
249
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
89
111
8.32
66.81
1.4
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
183
460
4.26
65.93
6.3
6.6
mmol/l
24.4
24.4
0.08
171
420
(3037522) Nuclear Ab [Titer] in Serum
414
1740
2.71
64.94
1.4
1.3
titre
604.1
615.6
0.04
87
308
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
801
4535
2.23
64.76
4.1
2.9
u/l
32.7
35.8
0.41
768
4281
(3013707) Erythrocyte sedimentation rate by Westergren method
1507
11005
2.28
62.97
5.7
3.3
mm/h
12.1
9.1
12.26
1434
10113
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
231
714
3.51
61.84
3.7
3.4
pmol/l
4.4
4.6
3.07
223
638
(3033658) Prothrombin time (PT) actual/Normal
608
3133
2.32
61.05
5.9
3.0
%
84.9
95.8
18.34
601
3056
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
76
87
9.02
61.05
1.4
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
653
3509
2.24
58.97
10.2
6.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
168
436
4.10
57.86
20.9
8.0
mmol/l
24.3
24.3
0.01
157
410
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
155
381
4.31
57.39
6.4
2.6
mmol/l
24.3
24.3
0.02
144
350
(3042936) Bacteria identified in Isolate by Culture
361
1517
2.66
56.03
2.5
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
677
3776
2.16
55.04
3.4
2.4
e6/l
153.7
55.9
0.60
551
2803
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
132
301
4.61
53.73
2.6
2.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
37
14
26.86
53.68
2.9
2.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
130
297
4.60
52.78
2.0
1.6
g/l
1.2
1.2
0.02
123
281
(3005719) IgG [Mass/volume] in Serum or Plasma
253
916
3.00
51.82
2.8
2.5
g/l
10.4
10.5
0.26
232
830
(3004119) Hemoglobin [Mass/volume] in Venous blood
168
472
3.78
51.68
6.2
2.4
g/l
130.9
136.3
2.10
162
463
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
179
526
3.62
51.53
1.4
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
621
3443
2.14
50.54
3.3
2.4
e6/l
0.5
0.4
1.13
483
2483
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
124
285
4.56
49.95
2.1
1.6
g/l
0.2
0.2
0.30
117
269
(3018095) Leukocytes [#/volume] in Urine
750
4481
2.04
49.79
4.0
2.8
e6/l
114.9
78.1
0.41
585
3027
(3027945) Reticulocytes/100 erythrocytes in Blood
261
984
2.88
49.60
2.4
2.6
%
1.9
1.6
4.47
245
850
(3017181) Myelocytes/100 leukocytes in Blood
266
1015
2.85
49.43
4.7
4.2
%
0.9
0.9
0.11
82
247
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
73
103
7.30
49.25
1.3
1.2
u/ml
1.8
2.9
0.49
20
40
(3031040) Bacteria [#/volume] in Urine by Automated count
1241
8848
1.97
49.17
4.7
3.2
e6/l
687.2
3784.9
1.69
21
89
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
140
358
4.11
49.09
5.7
2.3
%
1.2
1.3
0.96
135
352
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
73
105
7.16
48.41
1.4
1.2
u/ml
2.7
2.8
0.02
32
42
(3000850) Epithelial cells [#/volume] in Urine
481
2450
2.25
48.17
2.7
2.0
e6/l
4.2
4.7
0.48
438
2089
(3044640) Blood type and Crossmatch panel - Blood
680
3960
2.06
48.13
2.8
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
609
3417
2.10
47.57
3.2
2.4
—
—
—
0
0
(3020891) Body temperature
128
317
4.23
46.82
5.0
3.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
152
5.85
46.71
1.5
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
595
3333
2.09
46.52
2.9
2.0
umol/l
2578.8
4241.1
0.58
514
2963
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
937
6156
1.94
46.46
4.2
3.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
102
212
5.00
46.36
1.5
1.2
u/ml
122.9
110.0
0.34
14
41
(3025159) Blasts/100 leukocytes in Blood
243
917
2.86
45.97
4.7
4.3
%
0.0
0.1
1.71
68
187
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
685
4054
2.02
45.96
3.0
2.2
u/l
58.5
60.4
0.28
636
3714
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
135
353
4.01
45.89
5.8
2.3
%
0.6
0.7
0.90
128
338
(3026782) Osmolality of Urine
455
2318
2.23
45.24
2.9
2.1
mosm/kgh2o
544.0
595.2
5.09
414
1925
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
77
126
6.30
45.21
1.5
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
120
292
4.29
44.91
2.3
1.8
ug/l
1.3
2.7
0.72
113
266
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
71
108
6.76
44.71
1.5
1.3
—
—
—
0
0
(44790049)
67
97
7.10
44.16
1.6
1.5
—
—
—
0
0
(44806118)
67
97
7.10
44.16
1.6
1.5
—
—
—
0
0
(44790048)
67
97
7.10
44.16
1.6
1.5
—
—
—
0
0
(44790047)
67
97
7.10
44.16
1.6
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
248
970
2.76
43.77
4.8
4.2
%
0.1
0.1
0.45
75
225
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
98
207
4.91
43.70
8.0
4.4
iu/ml
2204.8
853.3
0.34
25
24
(3009343) pH of Capillary blood
174
558
3.31
43.59
4.2
2.2
ph
7.4
7.4
1.08
30
47
(3028026) IgM [Mass/volume] in Serum or Plasma
199
692
3.07
43.53
2.3
2.0
g/l
1.3
1.5
0.39
182
638
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
171
543
3.34
43.52
4.2
2.2
mmol/l
1.6
1.5
0.17
122
392
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
198
687
3.07
43.47
1.9
1.5
—
—
—
0
0
(3013512) EKG study
618
3590
2.02
43.23
5.4
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1875
15889
2.57
43.09
22.0
8.5
mg/l
22.5
23.3
0.45
1620
11498
(3020682) Albumin/Creatinine [Ratio] in Urine
568
3212
2.05
42.74
4.1
3.4
mg/mmol
10.8
3.2
3.29
390
1925
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
175
571
3.25
42.60
4.2
2.2
kpa
5.1
5.2
0.89
163
526
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
90
181
5.15
42.47
1.5
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
104
237
4.56
42.30
1.4
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
133
372
3.75
41.07
4.6
2.4
mmol/l
25.4
25.4
0.03
127
361
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1444
11181
1.92
40.85
4.4
3.4
pmol/l
15.1
14.6
11.84
1357
10072
(40760892) CBC W Ordered Manual Differential panel - Blood
564
3227
2.02
40.80
7.2
4.1
—
—
—
0
0
(4306422)
62
90
7.06
40.76
1.3
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
235
930
2.72
40.43
4.7
4.0
%
0.5
0.6
0.48
65
182
(3037467) Urinalysis macro (dipstick) panel - Urine
1302
9814
1.85
39.38
4.8
3.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
61
92
6.79
38.71
1.2
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
68
115
6.07
38.63
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
99
234
4.39
38.44
1.3
1.2
u/ml
286.8
260.7
0.36
80
143
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
216
842
2.74
38.21
4.7
3.0
mmol/l
1.2
1.2
1.39
200
713
(3020630) Protein [Mass/volume] in Serum or Plasma
200
750
2.84
38.07
2.6
2.5
g/l
64.8
67.9
5.62
188
678
(3023520) Reticulocytes [#/volume] in Blood
190
694
2.91
37.97
2.6
2.8
e9/l
77.8
64.9
3.05
135
523
(3012516) Albumin [Mass/volume] in Urine
531
3047
1.99
37.68
3.5
2.8
mg/l
559.5
559.9
0.00
364
1825
(3035350) Ketones [Presence] in Urine by Test strip
973
6788
1.80
37.29
3.8
2.6
estimate
0.0
0.0
0.44
202
1133
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
173
606
3.02
37.25
4.1
2.1
ng/l
94.9
59.9
4.98
156
523
(4268621)
51
67
7.77
36.58
2.6
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
982
6931
1.78
35.66
3.8
2.7
estimate
0.0
0.0
1.08
193
1133
(3052851) Hemolysis interference index of Serum or Plasma
108
290
3.87
35.33
3.7
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
971
6855
1.77
35.03
5.0
3.7
estimate
0.0
0.0
0.50
205
1169
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
89
209
4.40
34.84
3.5
3.4
ratio
1.3
1.3
—
6
13
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
149
502
3.12
34.28
1.8
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
90
216
4.30
34.26
3.5
3.3
mg/l
27.6
29.7
0.13
70
179
(3009508) Creatinine [Moles/volume] in Urine
577
3509
1.88
33.90
3.4
2.8
mmol/l
8.1
8.7
2.41
493
2945
(3034860) Kappa light chains.free [Mass/volume] in Serum
90
218
4.26
33.85
3.5
3.3
mg/l
50.6
35.0
0.90
71
182
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
98
253
4.01
33.85
1.3
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
46
59
7.94
33.66
1.4
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
256
1152
2.39
33.42
3.9
2.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
73
151
4.97
33.35
4.1
1.6
%
16.6
17.3
0.51
38
67
(3010421) pH of Blood
87
211
4.25
32.67
4.2
2.9
ph
7.4
7.4
0.20
78
174
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
515
3050
1.91
32.66
2.9
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
58
99
5.99
32.64
1.5
2.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
79
179
4.54
32.35
4.3
2.7
mmol/l
2.3
2.4
0.19
50
119
(3026008) Bacteria identified in Urine by Culture
507
3018
1.89
31.51
3.2
2.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
60
110
5.58
31.35
1.5
2.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
71
155
4.70
30.43
5.7
1.9
—
—
—
0
0
(3015736) pH of Urine
759
5149
1.74
30.29
3.6
2.5
—
5.7
—
0
11
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1665
14020
1.88
30.23
5.3
3.9
mu/l
1.9
2.2
0.76
1567
12680
(3024471) HLA-A [Type]
30
25
12.15
29.88
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
30
25
12.15
29.88
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
113
351
3.34
29.70
2.4
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
461
2708
1.90
29.62
1.8
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1872
16471
2.18
29.06
27.5
8.5
mmol/l
139.5
139.9
8.93
1845
15861
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
377
2085
1.98
28.92
2.8
2.3
e6/l
1.2
1.0
0.67
223
1127
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
106
322
3.41
28.85
3.7
5.9
%
1.6
1.6
0.17
94
301
(3024928) Oxygen saturation in Venous blood
66
142
4.76
28.80
8.0
2.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
274
1357
2.17
28.27
1.9
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1607
13485
1.79
28.21
27.0
10.8
%
13.7
13.4
9.62
1582
13125
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
231
1072
2.29
27.92
2.1
2.3
g/l
0.2
0.2
0.76
216
1010
(3023103) Potassium [Moles/volume] in Serum or Plasma
1875
16567
2.15
27.82
27.7
8.6
mmol/l
4.0
4.0
1.22
1845
15924
(3017143) Hepatitis C virus Ab [Presence] in Serum
323
1716
2.04
27.65
1.7
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
83
221
3.87
27.48
1.5
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
490
2998
1.82
27.42
3.5
2.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
29
10.47
27.13
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
69
162
4.37
27.03
3.8
3.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
791
5560
1.67
26.90
2.7
2.0
nmol/l
74.5
77.1
1.94
731
5004
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
357
1991
1.95
26.55
2.9
2.3
e6/l
2.7
1.8
1.30
205
1033
(3015235) Bicarbonate [Moles/volume] in Capillary blood
71
173
4.21
26.52
4.8
2.0
mmol/l
24.6
24.9
0.19
64
146
(3019309) Folate [Moles/volume] in Red Blood Cells
352
1959
1.95
26.32
1.7
1.6
nmol/l
1194.8
1096.4
1.21
289
1397
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
274
1399
2.10
26.03
3.0
2.6
umol/l
10.6
7.7
0.87
238
1235
(3048929) Epstein Barr virus Ab [Presence] in Serum
122
429
2.95
26.01
1.4
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
100
313
3.30
25.96
3.9
6.0
%
0.8
0.9
1.07
89
293
(3015171) Extractable nuclear Ab [Units/volume] in Serum
128
466
2.86
25.62
1.2
1.2
u/ml
2.7
0.6
0.63
11
46
(3051651) Icteric interference index of Serum or Plasma
35
45
7.89
25.54
2.9
3.1
—
—
—
0
0
(3036603) Volume of Urine
37
51
7.36
25.45
2.1
1.9
ml
1953.1
1837.6
—
9
8
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
244
1202
2.16
25.41
2.8
2.4
u/l
37.6
44.3
0.64
213
1057
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
65
156
4.26
24.77
1.6
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
50
7.30
24.60
1.5
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
71
185
3.93
24.24
3.6
1.6
g/l
132.3
136.6
0.54
54
109
(3015377) Calcium [Moles/volume] in Serum or Plasma
647
4411
1.67
24.17
3.3
3.1
mmol/l
2.3
2.4
1.80
570
3838
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
47
89
5.37
23.74
1.3
1.2
titre
76.3
161.7
—
8
18
(3021901) Oxygen saturation in Capillary blood
53
113
4.78
23.40
4.8
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
359
2086
1.87
23.34
1.6
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
67
175
3.92
22.81
2.3
2.3
umol/l
33.9
39.1
0.41
60
147
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
723
5134
1.62
22.68
2.0
1.7
pmol/l
97.3
97.9
0.14
397
2636
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
65
167
3.98
22.63
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
83
252
3.39
22.63
1.5
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
535
3521
1.69
22.60
4.2
2.9
estimate
0.0
0.0
0.05
196
1136
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
68
181
3.85
22.55
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
68
181
3.85
22.55
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
144
595
2.52
22.46
2.8
2.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
74
210
3.61
22.37
1.4
1.5
g/l
0.9
0.8
0.18
55
161
(3022313) Gas panel - Capillary blood
117
438
2.77
22.22
4.1
2.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
52
114
4.65
22.21
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
52
114
4.65
22.21
2.4
2.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
32
44
7.36
22.05
1.5
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
231
1178
2.08
21.87
1.5
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
97
331
3.02
21.81
1.3
1.2
u/ml
39.0
48.7
—
9
17
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
94
315
3.07
21.81
3.8
2.4
mg/l
1.7
1.1
7.86
87
289
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
32
45
7.20
21.62
1.5
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
23
21
11.05
21.55
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
41
75
5.55
21.50
1.9
2.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
95
324
3.02
21.38
1.4
1.3
—
1681.8
—
0
11
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
110
407
2.79
21.36
3.9
2.2
mmol/l
24.4
24.8
0.94
101
383
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1674
14588
1.70
21.35
6.4
4.1
mmol/mol
39.8
38.0
12.63
1578
13426
(3011412) CD3 cells [#/volume] in Blood
51
115
4.52
21.05
2.1
3.2
e9/l
1.1
1.2
0.24
37
61
(3007164) IgA [Mass/volume] in Serum or Plasma
432
2740
1.72
20.68
1.7
1.4
g/l
2.4
2.3
0.27
296
1660
(3014148) Varicella zoster virus Ab [Titer] in Serum
61
160
3.89
20.66
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
52
121
4.38
20.64
2.5
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
42
82
5.20
20.53
3.3
2.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
104
382
2.81
20.48
1.2
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
95
333
2.94
20.38
1.4
1.3
titre
104.7
108.9
0.04
15
36
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
737
5366
1.57
20.27
4.0
2.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
48
107
4.56
20.10
1.3
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
33
52
6.43
20.10
1.2
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
38
69
5.59
20.09
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
31
46
6.82
19.96
1.3
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
37
66
5.68
19.92
1.4
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
37
66
5.68
19.92
1.5
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
108
411
2.71
19.89
1.3
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
49
113
4.41
19.68
1.4
1.2
g/l
7.2
6.4
0.53
33
75
(3028192) IgG subclass 2 [Mass/volume] in Serum
49
113
4.41
19.68
1.4
1.2
g/l
2.6
3.0
0.94
33
74
(3024139) IgG subclass 3 [Mass/volume] in Serum
49
113
4.41
19.68
1.4
1.2
g/l
0.4
0.4
0.18
33
73
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
40
78
5.20
19.58
1.5
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
40
78
5.20
19.58
1.5
2.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
40
78
5.20
19.58
1.5
2.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
75
238
3.23
19.08
1.3
1.2
u/ml
61.1
60.2
0.01
11
18
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
42
88
4.85
18.95
1.8
2.6
%
13.4
13.5
0.01
25
40
(3004451) EKG impression Narrative
20
18
11.20
18.88
1.5
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1741
15494
1.69
18.62
20.2
7.7
ml/min/173m2
82.2
86.3
11.58
1528
12334
(4062490)
48
115
4.24
18.38
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
41
87
4.78
18.23
1.5
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
36
70
5.21
17.69
1.4
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
38
79
4.88
17.31
1.4
1.2
e6/l
2334.5
3183.4
0.22
24
59
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
67
211
3.24
17.28
1.1
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
56
157
3.63
17.28
4.2
9.6
mmol/l
11.5
11.7
0.12
46
138
(3018572) Chloride [Moles/volume] in Blood
56
158
3.61
17.12
4.2
9.6
mmol/l
105.2
104.9
0.16
46
139
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
27
41
6.65
17.02
2.5
2.8
%
88.7
98.6
0.43
27
41
(3005322) IgE [Units/volume] in Serum or Plasma
175
882
2.07
17.02
1.4
1.2
u/ml
324.3
283.6
0.17
167
811
(3000494) Fungus identified in Specimen by Culture
278
1639
1.80
16.91
1.7
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
395
2570
1.66
16.85
1.7
1.4
nmol/l
18.8
21.1
2.54
346
2140
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
370
2368
1.68
16.81
1.3
1.2
iu/ml
36.7
31.4
0.26
101
721
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1325
11200
1.49
16.62
3.9
2.7
u/l
57.2
43.2
5.66
1255
10446
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
197
1053
1.96
16.25
2.5
2.4
au/ml
16.0
25.2
—
8
72
(3030905) Polymorphonuclear cells [#/volume] in Blood
72
246
2.99
16.20
3.3
3.3
e9/l
4.2
3.8
0.72
72
246
(3045788) Cell count panel - Pleural fluid
31
57
5.50
16.19
1.3
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
35
72
4.92
16.15
1.4
1.1
pmol/l
347.8
278.6
0.49
26
49
(3047181) Lactate [Moles/volume] in Blood
70
236
3.03
16.12
4.2
7.3
mmol/l
1.2
1.3
0.28
61
197
(3040151) Glucose [Moles/volume] in Capillary blood
37
80
4.69
16.11
9.5
2.7
mmol/l
7.4
6.8
0.54
32
63
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
73
253
2.95
16.02
3.7
3.5
%
61.3
55.0
4.86
73
253
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
37
82
4.57
15.64
1.4
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
182
959
1.98
15.64
1.3
1.3
au/ml
40.4
46.8
0.17
12
51
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
188
1005
1.95
15.49
2.8
2.1
ml/min/173m2
59.2
79.2
8.55
83
327
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
57
174
3.34
15.48
1.5
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
12
12.57
15.14
5.3
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
19
22
8.70
15.01
1.2
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
81
308
2.69
14.98
1.4
1.2
u/ml
3.6
2.5
—
9
25
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
70
247
2.89
14.90
1.3
1.2
u/ml
30.9
1.7
—
6
16
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
109
479
2.34
14.88
1.4
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
38
90
4.28
14.80
2.3
3.3
e6/l
501.8
496.9
0.02
33
78
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
99
418
2.43
14.77
1.7
1.6
iu/ml
0.0
0.2
0.66
16
66
(40768797) Stomach Pathology biopsy report
294
1828
1.71
14.76
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
81
311
2.67
14.71
1.4
1.2
u/ml
22.5
5.1
1.09
19
47
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
80
306
2.68
14.64
1.4
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
34
76
4.53
14.24
1.2
1.1
u/l
1.1
1.0
0.24
14
35
(3000475) Leukocytes [#/volume] in Synovial fluid
73
271
2.75
14.16
1.6
1.5
e6/l
7307.6
9646.6
0.48
54
204
(40761511) CBC panel - Blood by Automated count
1873
17287
1.72
14.07
19.2
7.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
42
112
3.80
13.97
2.2
2.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
65
229
2.89
13.89
1.1
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
31
66
4.75
13.76
1.7
2.4
au/ml
123.0
130.3
—
8
9
(3025941) Bacteria identified in Stool by Culture
152
792
1.99
13.48
1.3
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
54
174
3.16
13.47
1.1
1.1
g/l
1.6
1.4
2.42
49
156
(3021788) Differential panel - Synovial fluid
58
195
3.03
13.47
1.4
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
23
7.88
13.15
1.2
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
31
69
4.54
13.06
1.3
1.2
e6/l
15056.7
117714.9
0.96
15
44
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
338
2246
1.60
12.98
1.3
1.2
u/ml
6.6
11.4
0.85
122
910
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
55
185
3.02
12.77
1.2
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
79
323
2.50
12.66
2.2
2.1
g/l
9.7
10.3
0.60
68
259
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
39
107
3.69
12.48
1.3
1.1
u/l
67.3
60.1
0.21
33
68
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1912
17858
1.73
12.31
15.4
7.7
u/l
28.9
27.9
1.74
1872
17099
(3041096) Erythrocytes [Presence] in Urine by Automated
519
3840
1.46
12.00
3.5
2.4
—
—
—
0
0
(3000492) Spirometry study
255
1612
1.66
11.92
1.7
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
36
97
3.76
11.83
3.5
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
36
97
3.76
11.83
3.5
4.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
172
976
1.83
11.78
3.6
2.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
38
107
3.60
11.73
1.6
3.0
%
39.0
40.3
—
5
14
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
46
148
3.15
11.54
1.3
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
25
52
4.85
11.42
1.2
1.1
iu/ml
134.6
162.1
0.31
25
52
(21494890) Protein electrophoresis panel - 24 hour Urine
28
65
4.35
11.22
2.7
2.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
93
437
2.18
10.88
1.8
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
353
2.31
10.88
2.2
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
353
2.31
10.88
2.2
2.1
g/l
6.9
6.9
0.06
61
257
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
329
2262
1.54
10.76
2.9
2.9
mmol/l
2.4
2.4
0.53
283
1988
(3019150) Specific gravity of Urine by Refractometry
409
2943
1.48
10.76
4.4
2.8
kg/l
1.0
1.0
1.95
65
405
(4035726)
200
1219
1.71
10.71
1.7
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
33
91
3.67
10.52
1.5
1.3
nmol/l
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
79
353
2.28
10.45
2.3
2.1
g/l
3.8
3.6
0.19
61
237
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
43
143
3.05
10.24
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1247
10881
1.35
10.22
3.2
2.9
—
—
—
0
0
(3035880) pH of Pleural fluid
16
24
6.71
10.18
1.4
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
58
228
2.59
10.14
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
46
161
2.90
10.03
2.3
1.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
54
207
2.65
9.93
2.4
2.0
ug/min
114.4
43.5
0.99
32
130
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1710
15744
1.45
9.87
4.4
3.2
mmol/l
1.4
1.3
7.13
1624
14422
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
32
5.66
9.74
1.4
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
67
290
2.35
9.56
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
355
2541
1.48
9.50
1.7
1.5
pmol/l
19142304.4
47048312.1
0.63
303
2151
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
62
260
2.42
9.49
1.4
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
249
1655
1.57
9.43
1.4
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
83
396
2.14
9.39
1.5
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
179
1101
1.68
9.27
4.4
2.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
47
175
2.72
9.16
2.0
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
68
305
2.27
8.96
1.6
1.9
iu/l
2.9
4.7
1.24
22
125
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
339
2.19
8.85
2.3
2.1
g/l
3.0
2.9
0.54
62
248
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
33
103
3.24
8.76
2.2
2.5
pg
32.8
32.5
0.11
33
103
(3044927) Protein electrophoresis panel - Urine
27
74
3.68
8.72
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
54
222
2.47
8.65
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
18
36
5.03
8.61
1.8
2.8
e6/l
198.5
176.8
0.15
13
19
(3016650) Hepatitis A virus Ab [Presence] in Serum
55
229
2.44
8.58
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
371
2.11
8.52
1.2
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
26
71
3.69
8.44
2.5
3.0
mg/l
7.3
9.0
0.61
15
61
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
21
49
4.32
8.40
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
21
49
4.32
8.40
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1690
15652
1.39
8.35
4.8
3.6
mmol/l
5.9
5.7
6.70
1592
14218
(40768446) Kidney Pathology biopsy report
10
11
9.12
8.08
2.4
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
66
306
2.19
8.06
2.6
2.3
g/l
0.9
1.1
0.15
56
259
(3000093) Morphology [Interpretation] in Blood Narrative
29
89
3.29
7.93
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
18
39
4.64
7.87
1.1
1.2
—
—
—
0
0
(4094501)
69
329
2.13
7.87
1.1
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
35
121
2.92
7.86
1.6
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
34
116
2.96
7.81
1.4
1.6
%
52.7
51.0
0.07
26
84
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
85
3.32
7.79
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
85
3.32
7.79
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
85
3.32
7.79
1.1
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
13
21
6.22
7.71
1.9
1.6
ug/l
43.2
47.8
0.19
13
21
(3024522) Salmonella sp identified in Specimen by Organism specific culture
42
163
2.61
7.61
1.3
1.4
—
—
—
0
0
(4010399)
151
938
1.66
7.55
1.4
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
33
113
2.95
7.54
1.5
1.2
mg/l
37.0
38.4
0.09
27
89
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
33
113
2.95
7.54
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
28
87
3.25
7.52
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
87
3.25
7.52
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
28
87
3.25
7.52
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
32
108
2.99
7.50
4.0
4.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
42
165
2.58
7.43
1.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
17
37
4.62
7.40
2.4
1.9
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
13
22
5.94
7.37
1.8
3.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
79
407
1.98
7.34
1.3
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
50
4.03
7.34
1.4
2.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
50
4.03
7.34
1.4
2.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
50
4.03
7.34
1.4
2.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
50
4.03
7.34
1.4
2.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
80
414
1.97
7.34
1.3
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
25
74
3.40
7.24
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
79
411
1.96
7.15
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
409
3162
1.36
6.92
1.3
1.2
u/ml
1.4
1.9
0.32
99
806
(3048689) Calprotectin [Mass/mass] in Stool
260
1864
1.45
6.81
2.6
2.5
ug/g
126.2
130.9
0.10
208
1491
(3045716) Anion gap in Serum or Plasma
18
44
4.11
6.81
2.6
1.8
mmol/l
10.6
9.3
0.28
13
33
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
40
4.27
6.74
1.4
3.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
40
4.27
6.74
1.4
3.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
40
4.27
6.74
1.4
3.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1586
14692
1.31
6.74
28.0
11.0
g/l
333.1
334.2
4.71
1579
14561
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
372
2849
1.37
6.66
1.6
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1745
16401
1.36
6.63
4.7
3.6
mmol/l
1.4
1.5
24.49
1661
15128
(3005988) Vibrio sp identified in Specimen by Organism specific culture
40
163
2.48
6.60
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
40
163
2.48
6.60
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1752
16490
1.36
6.49
4.7
3.6
mmol/l
4.6
5.0
42.44
1671
15268
(3028433) Virus identified in Specimen by Culture
18
46
3.94
6.43
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
67
343
1.98
6.38
1.2
1.2
—
—
—
0
0
(4015189)
10
15
6.69
6.31
3.0
2.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
39
161
2.45
6.28
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
91
523
1.77
6.08
1.5
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
81
1394
0.56
6.08
1.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
30
111
2.73
6.01
1.3
1.4
—
—
—
0
0
(4027681)
25
84
3.00
5.95
1.5
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
66
346
1.94
5.90
2.8
2.7
g/l
0.4
0.2
0.87
33
145
(3003181) Sodium [Moles/volume] in Urine
31
118
2.65
5.89
1.2
1.2
mmol/l
69.3
76.8
0.47
25
96
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
29
107
2.73
5.85
2.3
2.8
e6/l
485.3
620.3
—
10
46
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
38
161
2.38
5.81
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
24
80
3.02
5.80
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1771
16766
1.34
5.76
5.2
3.9
mmol/l
2.7
3.0
38.20
1685
15417
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
65
3.25
5.72
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
37
4.07
5.62
1.1
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
99
598
1.69
5.57
3.8
2.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
185
1297
1.47
5.46
1.7
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
726
6227
1.25
5.45
2.1
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
38
3.97
5.43
1.4
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
38
3.97
5.43
1.4
1.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
27
100
2.72
5.43
1.6
1.2
e6/l
278720.5
46416.7
0.60
20
68
(3044941) Cell count panel - Synovial fluid
39
173
2.28
5.40
1.5
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
143
2087
0.66
5.37
1.7
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
84
2.88
5.35
1.7
1.4
%
21.4
35.4
1.19
18
50
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
30
4.35
5.29
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
12
26
4.63
5.25
1.2
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
59
3.24
5.16
1.2
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
18
54
3.35
5.16
2.1
2.0
ml
912.0
544.9
0.90
12
37
(3003694) ABO and Rh group [Type] in Blood
512
4245
1.27
5.08
1.5
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
27
4.46
5.03
1.1
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
22
76
2.91
5.03
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
231
1714
1.39
4.99
12.3
4.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
52
270
1.95
4.84
1.7
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
28
4.30
4.82
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
28
4.30
4.82
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
28
4.30
4.82
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
28
4.30
4.82
1.1
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1961
18969
1.45
4.78
32.5
12.8
e9/l
245.5
249.9
2.56
1935
18364
(21494814) CD8 cells/100 lymphocytes in Specimen
16
47
3.42
4.74
1.4
2.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
79
2.80
4.71
3.0
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
95
595
1.62
4.70
1.2
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
38
3.70
4.64
3.1
2.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
38
3.70
4.64
2.6
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
43
3.50
4.61
2.1
2.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
53
283
1.89
4.56
1.9
1.4
e6/l
151.4
1221.2
1.02
48
225
(3026389) Candida sp identified in Specimen by Organism specific culture
32
141
2.29
4.54
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
241
1829
1.36
4.54
1.4
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1962
19001
1.44
4.53
32.7
12.8
g/l
137.1
140.4
17.98
1947
18640
(3035941) MCH [Entitic mass]
1961
18990
1.44
4.53
32.3
12.7
pg
30.3
30.4
0.30
1945
18633
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
31
135
2.31
4.52
4.2
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
1961
18991
1.44
4.52
32.4
12.7
fl
91.0
90.6
2.48
1945
18633
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
53
284
1.89
4.51
1.8
1.3
e6/l
8.9
10.0
0.08
48
213
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
20
70
2.87
4.49
1.0
1.1
nmol/l
0.1
3.4
—
5
17
(3026361) Erythrocytes [#/volume] in Blood
1961
18994
1.43
4.48
32.4
12.8
e12/l
4.6
4.6
12.15
1932
18326
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
88
2.63
4.39
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1666
15791
1.26
4.36
25.2
9.5
%
40.3
41.1
4.02
1285
12329
(3010813) Leukocytes [#/volume] in Blood
1961
19005
1.43
4.35
32.5
12.8
e9/l
6.9
6.4
5.30
1932
18329
(3004616) Nuclear Ab [Presence] in Serum
33
151
2.20
4.30
1.4
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
61
2.97
4.28
2.0
1.8
—
—
—
0
0
(3019225) pH of Specimen
184
1365
1.38
4.01
4.9
2.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
97
636
1.55
4.00
2.3
2.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
21
81
2.61
3.97
3.4
2.8
%
39.7
38.3
0.08
12
28
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
68
410
1.68
3.95
3.2
3.8
u/ml
80.8
509.3
1.13
57
348
(3017569) Oxygen content in Arterial blood
12
33
3.65
3.92
2.1
3.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
88
2.51
3.88
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
29
133
2.20
3.79
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
21
83
2.54
3.79
3.0
2.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
8
8.77
3.77
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
72
2.65
3.72
2.0
1.5
u/l
1.8
4.9
1.36
11
35
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
132
938
1.43
3.70
1.2
1.2
iu/ml
154.4
142.9
0.11
49
360
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
30
3.68
3.63
1.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
40
3.26
3.62
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
40
3.26
3.62
1.3
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
35
3.44
3.61
1.9
2.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
25
110
2.29
3.61
1.2
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
111
2.27
3.54
1.5
1.4
promille
1.4
1.3
0.09
19
92
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
25
111
2.27
3.54
1.2
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
49
279
1.77
3.51
2.0
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
145
1059
1.40
3.50
2.6
2.8
e9/l
4.1
3.9
0.28
122
841
(3013293) Extractable nuclear Ab [Presence] in Serum
8
13
6.17
3.50
1.5
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
30
145
2.08
3.47
1.3
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
199
1532
1.33
3.44
1.5
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
133
2.12
3.39
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
70
444
1.60
3.38
2.4
2.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
26
120
2.18
3.38
1.2
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
242
1922
1.29
3.34
1.4
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
37
3.25
3.34
1.3
3.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
14
5.73
3.34
1.8
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
14
5.73
3.34
1.8
1.2
%
61.6
101.1
—
8
14
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
32
3.45
3.33
1.2
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
49
2.87
3.19
1.3
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
49
2.87
3.19
1.1
1.1
miu/ml
1445.8
1623.2
0.26
14
49
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
49
2.87
3.19
1.3
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
20
4.51
3.11
2.8
2.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
17
68
2.51
3.04
1.5
1.5
—
1671585.7
—
0
7
(3015183) Erythrocyte sedimentation rate
21
93
2.27
3.03
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
87
2.31
3.00
1.9
1.3
u/ml
1.1
0.2
0.74
13
38
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
70
460
1.54
2.94
1.2
1.3
miu/ml
174.5
209.9
0.36
25
223
(3004716) Salmonella sp identified in Stool by Organism specific culture
105
752
1.42
2.88
1.5
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
22
4.10
2.88
4.2
3.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
13
5.40
2.87
1.0
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
9
6.68
2.86
1.0
1.1
umol/24h
2.1
1.5
—
6
9
(3006576) Bicarbonate [Moles/volume] in Blood
6
9
6.68
2.86
5.5
5.1
mmol/l
25.3
24.2
—
6
9
(40768800) Prostate Pathology biopsy report
24
467
0.51
2.86
1.3
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
129
2.03
2.85
1.1
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
22
103
2.15
2.80
1.3
1.1
—
42.3
—
0
10
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
71
2.40
2.80
5.9
7.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
18
4.45
2.79
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
61
394
1.56
2.78
2.7
2.5
u/l
10611.9
3626.6
0.58
23
148
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
23
3.92
2.77
1.2
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
6
8.34
2.75
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
6
8.34
2.75
1.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
13
48
2.72
2.71
1.7
2.1
umol/l
176.5
115.2
—
6
25
(3045142) Bone marrow Pathology biopsy report
26
132
1.98
2.70
1.5
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
10
6.01
2.69
1.2
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
92
2.18
2.67
1.6
1.7
u/field
3.0
1.9
0.26
12
37
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
113
2.05
2.61
4.9
5.4
u/ml
58.6
58.3
—
8
36
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
27
141
1.93
2.60
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
445
3876
1.19
2.59
1.7
1.6
mmol/l
1.5
1.4
2.98
382
3278
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
160
1248
1.30
2.58
4.0
4.4
ug/l
9.8
20.0
0.76
129
1005
(3022621) pH of Urine by Test strip
116
863
1.36
2.57
2.7
2.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(4034850)
69
468
1.49
2.55
11.3
6.0
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
7
16
4.38
2.47
1.3
1.3
%
109.6
109.7
—
7
16
(40757373) Influenza virus identified in Isolate
7
16
4.38
2.47
1.1
1.9
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
210
1.73
2.46
1.0
1.1
iu/ml
9.4
2473.0
—
8
52
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
21
3.82
2.46
2.4
2.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
21
3.82
2.46
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
96
2.09
2.42
1.4
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
34
2.95
2.41
2.0
1.4
ug/l
7.4
8.9
—
10
34
(3023410) Appearance of Cerebral spinal fluid
26
138
1.89
2.41
2.0
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
12
5.01
2.40
1.3
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
27
3.34
2.39
1.8
1.9
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
8
6.26
2.37
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
88
635
1.40
2.37
1.7
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
12
46
2.62
2.35
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
12
46
2.62
2.35
1.0
1.1
nmol/l
144.3
134.5
0.44
12
46
(3009214) Lutropin [Units/volume] in Serum or Plasma
69
478
1.46
2.32
1.7
1.4
u/l
11.1
7.7
0.84
59
394
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
28
3.22
2.30
1.2
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
13
4.62
2.27
3.2
1.8
u/field
1.2
0.4
—
6
13
(1761482) Bacteria [#/volume] in Urine by Culture
46
294
1.58
2.25
4.4
2.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
18
3.90
2.25
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
149
1.82
2.24
1.7
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
86
2.10
2.22
1.6
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
9
5.56
2.21
1.6
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
24
3.34
2.18
1.4
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
55
370
1.50
2.16
1.6
1.3
ug/g
220.5
297.2
2.05
35
218
(3047189) Immunofixation for 24 hour Urine
10
37
2.71
2.10
2.0
2.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
10
5.01
2.07
1.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
10
5.01
2.07
3.8
1.4
ng/l
87.1
80.6
—
5
10
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
15
4.01
2.04
3.0
4.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
36
223
1.62
2.02
1.1
1.1
u/ml
1.8
2.7
0.74
16
114
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
267
2273
1.20
2.02
2.0
1.8
%
1.5
1.4
1.09
222
2058
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
11
44
2.51
2.01
1.5
1.2
g/l
0.3
0.3
—
6
38
(40768795) Lymph node Pathology biopsy report
25
140
1.79
2.00
1.1
1.2
—
—
—
0
0
(44806071)
5
11
4.55
1.94
1.0
1.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
6
16
3.76
1.93
1.2
1.3
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
6
16
3.76
1.93
1.2
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
32
195
1.65
1.93
1.4
1.3
mmol/l
6.9
7.2
0.23
19
145
(3039443) Prostate specific Ag panel - Serum or Plasma
39
592
0.65
1.92
1.6
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
195
2331
0.82
1.92
1.3
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
22
3.19
1.88
1.1
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
5
12
4.17
1.82
2.2
1.7
mmol/l
1.1
1.2
—
5
12
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
29
2.76
1.79
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100
776
1.30
1.75
1.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
18
3.34
1.74
1.2
2.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
13
3.85
1.71
1.0
2.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
695
6421
1.12
1.71
3.7
4.3
ug/l
2.5
2.4
0.09
625
5859
(3044007) Cell count panel - Peritoneal fluid
6
19
3.16
1.66
1.3
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
97
1.86
1.66
2.3
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
31
2.58
1.65
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
31
2.58
1.65
1.3
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
26
157
1.66
1.65
1.2
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
14
3.57
1.61
1.2
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
14
3.57
1.61
3.6
4.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
14
3.57
1.61
1.2
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
32
2.50
1.59
1.3
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
32
2.50
1.59
1.3
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
8
32
2.50
1.59
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
63
2.07
1.59
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
42
289
1.46
1.55
2.0
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
39
265
1.48
1.53
1.2
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
53
382
1.40
1.53
1.1
1.1
u/ml
2.2
7.7
0.89
12
57
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
27
2.60
1.51
1.1
1.3
%
86.9
100.3
—
7
27
(3045424) Erythrocytes [Presence] in Urine
39
266
1.47
1.51
1.1
1.4
—
—
—
0
0
(1002224) Polysomnography panel
103
821
1.27
1.51
1.0
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
26
162
1.61
1.49
2.1
1.8
mg/l
23.3
25.3
—
9
44
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
87
1.84
1.45
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
48
344
1.40
1.44
1.1
1.1
u/ml
0.9
1.3
0.31
22
146
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
72
551
1.32
1.44
1.6
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
66
1.97
1.43
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
323
1.40
1.36
1.4
1.3
—
—
—
0
0
(4038314)
5
17
2.94
1.36
1.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
17
2.94
1.36
1.4
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
17
2.94
1.36
2.8
2.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
118
969
1.23
1.35
1.3
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
44
315
1.40
1.35
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
135
1125
1.21
1.35
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
42
2.15
1.33
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
42
2.15
1.33
1.6
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
47
2.13
1.33
3.1
3.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
44
316
1.40
1.33
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
24
2.50
1.30
1.2
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
44
318
1.39
1.29
1.0
1.1
u/ml
8.2
5.3
0.60
27
163
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
269
1.42
1.25
4.6
2.6
mg/l
20.7
28.8
1.04
25
144
(3011436) Histone Ab [Units/volume] in Serum
6
25
2.40
1.24
1.3
1.2
u/ml
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
64
1.88
1.18
1.2
2.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
40
290
1.39
1.17
1.1
1.1
u/ml
2.1
3.1
0.38
11
68
(3005570) Glucose [Moles/volume] in Urine
17
102
1.67
1.16
1.5
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
20
2.50
1.15
1.0
1.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
11
58
1.90
1.12
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
193
1692
1.15
1.10
2.0
2.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
31
2.26
1.10
1.0
1.1
—
—
—
0
0
(44806420)
5
21
2.38
1.09
1.6
2.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
32
2.19
1.08
1.3
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
38
279
1.37
1.05
1.1
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
41
305
1.35
1.05
1.0
1.1
u/ml
1.4
1.2
0.11
18
127
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
46
1.96
1.03
1.1
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
60
1.84
1.02
2.5
1.4
—
—
—
0
0
(4198724)
14
84
1.67
0.97
1.7
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
109
1.56
0.93
1.4
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
209
1872
1.13
0.90
2.1
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
638
6720
0.93
0.88
2.9
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
71
585
1.22
0.87
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
78
652
1.20
0.83
1.4
1.4
iu/l
26.6
28.7
0.21
69
559
(3017446) Testosterone [Moles/volume] in Serum or Plasma
200
1803
1.12
0.80
2.3
2.1
nmol/l
14.0
14.5
0.35
178
1643
(4211845)
11
66
1.67
0.78
3.6
2.8
—
—
—
0
0
(4146454)
15
98
1.53
0.78
2.9
2.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
34
1.77
0.76
1.3
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
24
2.08
0.74
1.4
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
55
1.64
0.73
1.2
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
100
867
1.16
0.73
2.2
2.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
14
92
1.52
0.72
1.1
1.1
iu/ml
16.9
10.9
—
5
28
(40768793) Breast Pathology biopsy report
24
321
0.74
0.71
1.2
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
40
1.75
0.71
1.1
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
180
1985
0.90
0.70
1.5
1.4
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
5
26
1.92
0.70
1.4
1.7
mg/l
1.8
1.8
—
5
21
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
26
1.92
0.70
1.2
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
26
1.92
0.70
1.2
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
26
1.92
0.70
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
41
1.71
0.70
2.3
2.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
26
196
1.33
0.67
1.3
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
10
62
1.61
0.65
2.3
1.2
%
—
60.4
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
29
1.72
0.64
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
81
702
1.16
0.62
2.1
2.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
63
1.59
0.61
3.5
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
545
5201
1.06
0.61
3.4
3.7
%
21.1
20.9
0.09
204
2334
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
88
1.48
0.60
1.1
1.5
mmol/l
10.9
12.0
—
6
24
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
54
1.48
0.57
1.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
48
403
1.19
0.55
1.6
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
61
524
1.17
0.54
2.1
1.6
mu/l
393.3
290.4
0.92
54
478
(3014599) Egg white IgE Ab [Units/volume] in Serum
14
99
1.42
0.54
1.0
1.0
u/ml
0.5
0.4
—
6
22
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
62
1.45
0.53
4.1
2.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
75
1.47
0.50
1.1
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
14
102
1.37
0.47
1.8
1.3
—
65.0
—
0
12
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
49
1.43
0.46
1.3
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
117
0.68
0.46
1.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
83
0.60
0.45
3.4
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
83
0.60
0.45
6.8
6.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
84
0.59
0.45
1.2
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
21
262
0.80
0.42
1.7
1.3
pmol/l
55.4
79.5
—
9
76
(3041806) Other cells [#/volume] in Blood by Manual count
8
56
1.43
0.42
1.5
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
92
0.65
0.42
1.2
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
158
1.27
0.41
1.5
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
1.0
2.3
umol/l
24.1
18.2
—
5
33
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
12
88
1.36
0.40
1.0
1.1
nmol/l
494.9
386.8
0.80
12
82
(3023430) Cat dander IgE Ab [Units/volume] in Serum
28
235
1.19
0.36
1.0
1.0
u/ml
3.0
5.6
0.74
13
87
(3050129) First trimester maternal screen panel - Serum or Plasma
25
297
0.84
0.34
1.2
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
37
322
1.15
0.32
4.1
3.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
25
212
1.18
0.30
1.0
1.0
u/ml
0.8
0.4
—
5
51
(3001019) Free T4 and TSH panel - Serum or Plasma
91
982
0.92
0.29
1.5
1.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
13
102
1.28
0.29
7.7
6.3
u/ml
38.6
131.0
—
5
22
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
14
112
1.25
0.28
2.1
2.0
nmol/l
20.0
20.0
0.00
14
107
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
277
0.86
0.25
1.4
1.4
—
—
—
0
0
(44813793)
12
96
1.25
0.24
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
143
1.19
0.23
1.1
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
94
0.74
0.22
1.0
1.1
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
10
0.00
0.21
0.0
1.1
—
175.1
—
0
10
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
262
0.88
0.21
1.4
1.4
—
—
—
0
0
(4212803)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
104
0.77
0.21
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
261
0.88
0.20
1.4
1.4
—
—
—
0
0
(4281824)
10
123
0.81
0.20
1.1
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
76
809
0.94
0.20
2.7
2.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
19
218
0.87
0.19
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
260
0.88
0.19
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
260
0.88
0.19
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
99
1.21
0.19
1.3
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
51
1.18
0.19
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
43
467
0.92
0.19
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
39
424
0.92
0.17
1.9
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
77
814
0.94
0.17
2.7
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
200
1936
1.04
0.17
4.6
3.7
%
31.0
30.9
0.03
159
1192
(3027008) Opiates [Presence] in Urine
77
812
0.95
0.16
2.7
2.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
12
102
1.18
0.15
1.0
1.0
u/ml
0.5
0.3
—
5
28
(3026470) Cobalt [Mass/volume] in Blood
9
81
1.11
0.15
2.4
2.0
ug/l
3.4
2.7
—
9
74
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
159
0.88
0.13
1.7
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
76
790
0.96
0.11
2.7
2.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
154
1.10
0.10
1.8
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
47
1.06
0.09
1.6
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
252
1.07
0.09
1.1
1.1
u/ml
1.2
3.0
1.26
12
92
(40765089) Chromosome analysis panel - Blood by G-banded
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
64
0.78
0.08
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
83
0.84
0.07
3.0
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
50
517
0.97
0.06
6.3
3.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
120
1.08
0.04
1.5
1.4
g/l
1.0
1.0
0.08
13
120
(4024509)
12
111
1.08
0.04
1.2
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
62
633
0.98
0.03
3.0
2.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
20
191
1.05
0.03
1.7
1.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
11
118
0.93
0.03
1.6
2.2
umol/l
3.3
6.1
—
6
83
(3025130) Human papilloma virus identified in Specimen
17
178
0.95
0.02
1.4
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
222
1.04
0.02
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
217
0.97
0.01
1.4
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
25
257
0.97
0.01
2.4
2.2
%
13.0
13.1
0.14
25
252
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
395
3940
1.00
0.00
2.4
2.8
ug/l
0.6
0.7
1.23
225
2358
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
95
1.05
0.00
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
215
0.98
0.00
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
75
753
1.00
0.00
2.7
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
70
696
1.01
0.00
1.7
1.9
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
66
0.91
0.00
1.8
1.2
umol/l
11.5
28.6
—
6
60
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
35.7
—
0
6
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
79
0.89
0.00
1.4
1.8
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
76
0.92
0.00
1.1
1.4
—
—
—
0
0
(4133840)
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
-0.00
0.0
1.0
—
11.1
—
0
5
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.0
—
1.6
—
0
5
(3036180) Methadone [Presence] in Urine
0
5
0.00
-0.00
0.0
2.8
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_MYOCARD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_MYOCARD | 1.922 [1.65, 2.24] | < 0.001 |
| Birth year | 0.993 [0.99, 1.0] | 0.121 |
During the follow-up period (1.1.1998 — 31.12.2019), 807 out of 3243 females with I9_MYOCARD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_MYOCARD | 1.902 [1.66, 2.18] | < 0.001 |
| Birth year | 0.982 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1142 out of 6956 males with I9_MYOCARD died.
Mortality risk
Mortality risk for people of age
years, who have I9_MYOCARD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.158% | 0.292% |
| 5 | 0.99% | 1.77% |
| 10 | 2.631% | 4.585% |
| 15 | 5.079% | 8.551% |
| 20 | 8.959% | 14.163% |
Relationships between endpoints
↥Index endpoint: I9_MYOCARD – Myocarditis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data